EASL Clinical Practice Guidelines

References

[1]Yano, M., Kumada, H., Kage, M., Ikeda, K., Shimamatsu, K., Inoue, O. et al. The long-term pathological evolution of chronic hepatitis C. Hepatology. 1996; 23: 13341340
CrossRef | PubMed

[2]Younossi, Z.M., Stepanova, M., Rafiq, N., Makhlouf, H., Younoszai, Z., Agrawal, R. et al. Pathologic criteria for nonalcoholic steatohepatitis: interprotocol agreement and ability to predict liver-related mortality. Hepatology. 2011; 53: 18741882
CrossRef | PubMed | Scopus (77)

[3]Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. The French METAVIR Cooperative Study Group. Hepatology. 1994; 20: 1520
CrossRef | PubMed

[4]Bedossa, P. and Poynard, T. An algorithm for the grading of activity in chronic hepatitis C. The METAVIR cooperative study group. Hepatology. 1996; 24: 289293
CrossRef | PubMed

[5]Tsochatzis, E., Bruno, S., Isgro, G., Hall, A., Theocharidou, E., Manousou, P. et al. Collagen proportionate area is superior to other histological methods for sub-classifying cirrhosis and determining prognosis. J Hepatol. 2014; 60: 948954
Abstract | Full Text | Full Text PDF

[6]DAmbrosio, R., Aghemo, A., Rumi, M.G., Ronchi, G., Donato, M.F., Paradis, V. et al. A morphometric and immunohistochemical study to assess the benefit of a sustained virological response in hepatitis C virus patients with cirrhosis. Hepatology. 2012; 56: 532543
CrossRef | PubMed | Scopus (43)

[7]Gailhouste, L., Le Grand, Y., Odin, C., Guyader, D., Turlin, B., Ezan, F. et al. Fibrillar collagen scoring by second harmonic microscopy: a new tool in the assessment of liver fibrosis. J Hepatol. 2010; 52: 398406
Abstract | Full Text | Full Text PDF | PubMed | Scopus (31)

[8]Ishak, K., Baptista, A., Bianchi, L., Callea, F., De Groote, J., Gudat, F. et al. Histological grading and staging of chronic hepatitis. J Hepatol. 1995; 22: 696699
Abstract | Full Text PDF | PubMed | Scopus (2704)

[9]Regev, A., Berho, M., Jeffers, L.J., Milikowski, C., Molina, E.G., Pyrsopoulos, N.T. et al. Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection. Am J Gastroenterol. 2002; 97: 26142618
CrossRef | PubMed

[10]Bedossa, P., Dargre, D., and Paradis, V. Sampling variability of liver fibrosis in chronic hepatitis C. Hepatology. 2003; 38: 14491457
CrossRef | PubMed | Scopus (1177)

[11]Brunetti, E., Silini, E., Pistorio, A., Cavallero, A., Marangio, A., Bruno, R. et al. Coarse vs. fine needle aspiration biopsy for the assessment of diffuse liver disease from hepatitis C virus-related chronic hepatitis. J Hepatol. 2004; 40: 501506
Abstract | Full Text | Full Text PDF | PubMed | Scopus (21)

[12]Rousselet, M.C., Michalak, S., Dupre, F., Croue, A., Bedossa, P., Saint-Andre, J.P. et al. Sources of variability in histological scoring of chronic viral hepatitis. Hepatology. 2005; 41: 257264
CrossRef | PubMed | Scopus (258)

[13]Bravo, A.A., Sheth, S.G., and Chopra, S. Liver biopsy. N Engl J Med. 2001; 344: 495500
CrossRef | PubMed | Scopus (964)

[14]Piccinino, F., Sagnelli, E., Pasquale, G., and Giusti, G. Complications following percutaneous liver biopsy. A multicentre retrospective study on 68,276 biopsies. J Hepatol. 1986; 2: 165173
Abstract | Full Text PDF | PubMed | Scopus (636)

[15]Mehta, S.H., Lau, B., Afdhal, N.H., and Thomas, D.L. Exceeding the limits of liver histology markers. J Hepatol. 2009; 50: 3641
Abstract | Full Text | Full Text PDF | PubMed | Scopus (116)

[16]Ransohoff, D.F. and Feinstein, A.R. Problems of spectrum and bias in evaluating the efficacy of diagnostic tests. N Engl J Med. 1978; 299: 926930
CrossRef | PubMed

[17]Poynard, T., Halfon, P., Castera, L., Munteanu, M., Imbert-Bismut, F., Ratziu, V. et al. Standardization of ROC curve areas for diagnostic evaluation of liver fibrosis markers based on prevalences of fibrosis stages. Clin Chem. 2007; 53: 16151622
CrossRef | PubMed | Scopus (140)

[18]Sebastiani, G., Castera, L., Halfon, P., Pol, S., Mangia, A., Di Marco, V. et al. The impact of liver disease aetiology and the stages of hepatic fibrosis on the performance of non-invasive fibrosis biomarkers: an international study of 2411 cases. Aliment Pharmacol Ther. 2011; 34: 12021216
CrossRef | PubMed | Scopus (31)

[19]Obuchowski, N.A. An ROC-type measure of diagnostic accuracy when the gold standard is continuous-scale. Stat Med. 2006; 25: 481493
CrossRef | PubMed | Scopus (52)

[20]Andrews, J., Guyatt, G., Oxman, A.D., Alderson, P., Dahm, P., Falck-Ytter, Y. et al. GRADE guidelines: 14. Going from evidence to recommendations: the significance and presentation of recommendations. J Clin Epidemiol. 2013; 66: 719725
Abstract | Full Text | Full Text PDF | PubMed | Scopus (56)

[21]Imbert-Bismut, F., Ratziu, V., Pieroni, L., Charlotte, F., Benhamou, Y., and Poynard, T. Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study. Lancet. 2001; 357: 10691075
Abstract | Full Text | Full Text PDF | PubMed | Scopus (994)

[22]Forns, X., Ampurdanes, S., Llovet, J.M., Aponte, J., Quinto, L., Martinez-Bauer, E. et al. Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model. Hepatology. 2002; 36: 986992
CrossRef | PubMed

[23]Wai, C.T., Greenson, J.K., Fontana, R.J., Kalbfleisch, J.D., Marrero, J.A., Conjeevaram, H.S. et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology. 2003; 38: 518526
CrossRef | PubMed | Scopus (1257)

[24]Patel, K., Gordon, S.C., Jacobson, I., Hezode, C., Oh, E., Smith, K.M. et al. Evaluation of a panel of non-invasive serum markers to differentiate mild from moderate-to-advanced liver fibrosis in chronic hepatitis C patients. J Hepatol. 2004; 41: 935942
Abstract | Full Text | Full Text PDF | PubMed | Scopus (244)

[25]Leroy, V., Monier, F., Bottari, S., Trocme, C., Sturm, N., Hilleret, M.N. et al. Circulating matrix metalloproteinases 1, 2, 9 and their inhibitors TIMP-1 and TIMP-2 as serum markers of liver fibrosis in patients with chronic hepatitis C: comparison with PIIINP and hyaluronic acid. Am J Gastroenterol. 2004; 99: 271279
CrossRef | PubMed | Scopus (140)

[26]Sud, A., Hui, J.M., Farrell, G.C., Bandara, P., Kench, J.G., Fung, C. et al. Improved prediction of fibrosis in chronic hepatitis C using measures of insulin resistance in a probability index. Hepatology. 2004; 39: 12391247
CrossRef | PubMed | Scopus (133)

[27]Adams, L.A., Bulsara, M., Rossi, E., DeBoer, B., Speers, D., George, J. et al. Hepascore: an accurate validated predictor of liver fibrosis in chronic hepatitis C infection. Clin Chem. 2005; 51: 18671873
CrossRef | PubMed | Scopus (276)

[28]Lok, A.S., Ghany, M.G., Goodman, Z.D., Wright, E.C., Everson, G.T., Sterling, R.K. et al. Predicting cirrhosis in patients with hepatitis C based on standard laboratory tests: results of the HALT-C cohort. Hepatology. 2005; 42: 282292
CrossRef | PubMed | Scopus (138)

[29]Islam, S., Antonsson, L., Westin, J., and Lagging, M. Cirrhosis in hepatitis C virus-infected patients can be excluded using an index of standard biochemical serum markers. Scand J Gastroenterol. 2005; 40: 867872
CrossRef | PubMed | Scopus (59)

[30]Fontana, R.J., Kleiner, D.E., Bilonick, R., Terrault, N., Afdhal, N., Belle, S.H. et al. Modeling hepatic fibrosis in African American and Caucasian American patients with chronic hepatitis C virus infection. Hepatology. 2006; 44: 925935
CrossRef | PubMed | Scopus (31)

[31]Koda, M., Matunaga, Y., Kawakami, M., Kishimoto, Y., Suou, T., and Murawaki, Y. FibroIndex, a practical index for predicting significant fibrosis in patients with chronic hepatitis C. Hepatology. 2007; 45: 297306
CrossRef | PubMed | Scopus (118)

[32]Vallet-Pichard, A., Mallet, V., Nalpas, B., Verkarre, V., Nalpas, A., Dhalluin-Venier, V. et al. FIB-4: an inexpensive and accurate marker of fibrosis in HCV infection. Comparison with liver biopsy and fibrotest. Hepatology. 2007; 46: 3236
CrossRef | PubMed | Scopus (261)

[33]Fontana, R.J., Goodman, Z.D., Dienstag, J.L., Bonkovsky, H.L., Naishadham, D., Sterling, R.K. et al. Relationship of serum fibrosis markers with liver fibrosis stage and collagen content in patients with advanced chronic hepatitis C. Hepatology. 2008; 47: 789798
CrossRef | PubMed | Scopus (100)

[34]Rosenberg, W.M., Voelker, M., Thiel, R., Becka, M., Burt, A., Schuppan, D. et al. Serum markers detect the presence of liver fibrosis: A cohort study. Gastroenterology. 2004; 127: 17041713
Abstract | Full Text | Full Text PDF | PubMed | Scopus (530)

[35]Cales, P., Oberti, F., Michalak, S., Hubert-Fouchard, I., Rousselet, M.C., Konate, A. et al. A novel panel of blood markers to assess the degree of liver fibrosis. Hepatology. 2005; 42: 13731381
CrossRef | PubMed | Scopus (309)

[36]Hui, A.Y., Chan, H.L., Wong, V.W., Liew, C.T., Chim, A.M., Chan, F.K. et al. Identification of chronic hepatitis B patients without significant liver fibrosis by a simple noninvasive predictive model. Am J Gastroenterol. 2005; 100: 616623
CrossRef | PubMed | Scopus (92)

[37]Zeng, M.D., Lu, L.G., Mao, Y.M., Qiu, D.K., Li, J.Q., Wan, M.B. et al. Prediction of significant fibrosis in HBeAg-positive patients with chronic hepatitis B by a noninvasive model. Hepatology. 2005; 42: 14371445
CrossRef | PubMed | Scopus (95)

[38]Kelleher, T.B., Mehta, S.H., Bhaskar, R., Sulkowski, M., Astemborski, J., Thomas, D.L. et al. Prediction of hepatic fibrosis in HIV/HCV co-infected patients using serum fibrosis markers: The SHASTA index. J Hepatol. 2005; 43: 7884
Abstract | Full Text | Full Text PDF | PubMed | Scopus (140)

[39]Sterling, R.K., Lissen, E., Clumeck, N., Sola, R., Correa, M.C., Montaner, J. et al. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection. Hepatology. 2006; 43: 13171325
CrossRef | PubMed | Scopus (401)

[40]Angulo, P., Hui, J.M., Marchesini, G., Bugianesi, E., George, J., Farrell, G.C. et al. The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD. Hepatology. 2007; 45: 846854
CrossRef | PubMed | Scopus (446)

[41]Harrison, S.A., Oliver, D., Arnold, H.L., Gogia, S., and Neuschwander-Tetri, B.A. Development and validation of a simple NAFLD clinical scoring system for identifying patients without advanced disease. Gut. 2008; 57: 14411447
CrossRef | PubMed | Scopus (179)

[42]Poynard, T., Munteanu, M., Deckmyn, O., Ngo, Y., Drane, F., Messous, D. et al. Applicability and precautions of use of liver injury biomarker FibroTest. A reappraisal at 7 years of age. BMC Gastroenterol. 2011; 11: 39
CrossRef | PubMed | Scopus (21)

[43]Imbert-Bismut, F., Messous, D., Thibaut, V., Myers, R.B., Piton, A., Thabut, D. et al. Intra-laboratory analytical variability of biochemical markers of fibrosis (Fibrotest) and activity (Actitest) and reference ranges in healthy blood donors. Clin Chem Lab Med. 2004; 42: 323333
CrossRef | PubMed

[44]Cales, P., Veillon, P., Konate, A., Mathieu, E., Ternisien, C., Chevailler, A. et al. Reproducibility of blood tests of liver fibrosis in clinical practice. Clin Biochem. 2008; 41: 1018
CrossRef | PubMed | Scopus (37)

[45]Fraser, J.R. and Gibson, P.R. Mechanisms by which food intake elevates circulating levels of hyaluronan in humans. J Intern Med. 2005; 258: 460466
CrossRef | Scopus (17)

[46]Volpi, N., Schiller, J., Stern, R., and Soltes, L. Role, metabolism, chemical modifications and applications of hyaluronan. Curr Med Chem. 2009; 16: 17181745
CrossRef | PubMed | Scopus (72)

[47]Piton, A., Poynard, T., Imbert-Bismut, F., Khalil, L., Delattre, J., Pelissier, E. et al. Factors associated with serum alanine transaminase activity in healthy subjects: consequences for the definition of normal values, for selection of blood donors, and for patients with chronic hepatitis C. MULTIVIRC Group. Hepatology. 1998; 27: 12131219
CrossRef | PubMed | Scopus (215)

[48]Poynard, T., Munteanu, M., Imbert-Bismut, F., Charlotte, F., Thabut, D., Le Calvez, S. et al. Prospective analysis of discordant results between biochemical markers and biopsy in patients with chronic hepatitis C. Clin Chem. 2004; 10: 10

[49]Sandrin, L., Fourquet, B., Hasquenoph, J.M., Yon, S., Fournier, C., Mal, F. et al. Transient elastography: a new noninvasive method for assessment of hepatic fibrosis. Ultrasound Med Biol. 2003; 29: 17051713
Abstract | Full Text | Full Text PDF | PubMed | Scopus (1039)

[50]Castera, L., Forns, X., and Alberti, A. Non-invasive evaluation of liver fibrosis using transient elastography. J Hepatol. 2008; 48: 835847
Abstract | Full Text | Full Text PDF | PubMed | Scopus (415)

[51]Roulot, D., Czernichow, S., Le Clesiau, H., Costes, J.L., Vergnaud, A.C., and Beaugrand, M. Liver stiffness values in apparently healthy subjects: influence of gender and metabolic syndrome. J Hepatol. 2008; 48: 606613
Abstract | Full Text | Full Text PDF | PubMed | Scopus (199)

[52]Kim, S.U., Choi, G.H., Han, W.K., Kim, B.K., Park, J.Y., Kim do, Y. et al. What are true normal liver stiffness values using FibroScan?: a prospective study in healthy living liver and kidney donors in South Korea. Liver Int. 2010; 30: 268274
CrossRef | PubMed | Scopus (36)

[53]Colombo, S., Belloli, L., Zaccanelli, M., Badia, E., Jamoletti, C., Buonocore, M. et al. Normal liver stiffness and its determinants in healthy blood donors. Dig Liver Dis. 2011; 43: 231236
Abstract | Full Text | Full Text PDF | PubMed | Scopus (19)

[54]Das, K., Sarkar, R., Ahmed, S.M., Mridha, A.R., Mukherjee, P.S., Dhali, G.K. et al. Normal liver stiffness measure (LSM) values are higher in both lean and obese individuals: a population-based study from a developing country. Hepatology. 2012; 55: 584593
CrossRef | PubMed | Scopus (20)

[55]Boursier, J., Konate, A., Guilluy, M., Gorea, G., Sawadogo, A., Quemener, E. et al. Learning curve and interobserver reproducibility evaluation of liver stiffness measurement by transient elastography. Eur J Gastroenterol Hepatol. 2008; 20: 693701
CrossRef | PubMed | Scopus (38)

[56]Fraquelli, M., Rigamonti, C., Casazza, G., Conte, D., Donato, M.F., Ronchi, G. et al. Reproducibility of transient elastography in the evaluation of liver fibrosis in patients with chronic liver disease. Gut. 2007; 56: 968973
CrossRef | PubMed | Scopus (404)

[57]Boursier, J., Konate, A., Gorea, G., Reaud, S., Quemener, E., Oberti, F. et al. Reproducibility of liver stiffness measurement by ultrasonographic elastometry. Clin Gastroenterol Hepatol. 2008; 6: 12631269
Abstract | Full Text | Full Text PDF | PubMed | Scopus (51)

[58]Castera, L., Foucher, J., Bernard, P.H., Carvalho, F., Allaix, D., Merrouche, W. et al. Pitfalls of liver stiffness measurement: a 5-year prospective study of 13,369 examinations. Hepatology. 2010; 51: 828835
PubMed

[59]Wong, G.L., Wong, V.W., Chim, A.M., Yiu, K.K., Chu, S.H., Li, M.K. et al. Factors associated with unreliable liver stiffness measurement and its failure with transient elastography in the Chinese population. J Gastroenterol Hepatol. 2011; 26: 300305
CrossRef | PubMed | Scopus (32)

[60]Lucidarme, D., Foucher, J., Le Bail, B., Vergniol, J., Castera, L., Duburque, C. et al. Factors of accuracy of transient elastography (fibroscan) for the diagnosis of liver fibrosis in chronic hepatitis C. Hepatology. 2009; : 10831089
CrossRef | PubMed | Scopus (114)

[61]Myers, R.P., Crotty, P., Pomier-Layrargues, G., Ma, M., Urbanski, S.J., and Elkashab, M. Prevalence, risk factors and causes of discordance in fibrosis staging by transient elastography and liver biopsy. Liver Int. 2010; 30: 14711480
CrossRef | PubMed | Scopus (38)

[62]Boursier, J., Zarski, J.P., de Ledinghen, V., Rousselet, M.C., Sturm, N., Lebail, B. et al. Determination of reliability criteria for liver stiffness evaluation by transient elastography. Hepatology. 2013; 57: 11821191
CrossRef | PubMed | Scopus (35)

[63]Parra-Ruiz, J., Sanjuan, C., Munoz-Medina, L., Vinuesa, D., Martinez-Perez, M.A., and Hernandez-Quero, J. Letter: accuracy of liver stiffness measurement a comparison of two different FibroScan devices. Aliment Pharmacol Ther. 2014; 39: 14341435
CrossRef

[64]Friedrich-Rust, M., Hadji-Hosseini, H., Kriener, S., Herrmann, E., Sircar, I., Kau, A. et al. Transient elastography with a new probe for obese patients for non-invasive staging of non-alcoholic steatohepatitis. Eur Radiol. 2010; 20: 23902396
CrossRef | PubMed | Scopus (38)

[65]de Ledinghen, V., Vergniol, J., Foucher, J., El-Hajbi, F., Merrouche, W., and Rigalleau, V. Feasibility of liver transient elastography with FibroScan using a new probe for obese patients. Liver Int. 2010; 30: 10431048
CrossRef | PubMed | Scopus (79)

[66]Myers, R.P., Pomier-Layrargues, G., Kirsch, R., Pollett, A., Duarte-Rojo, A., Wong, D. et al. Feasibility and diagnostic performance of the FibroScan XL probe for liver stiffness measurement in overweight and obese patients. Hepatology. 2012; 55: 199208
CrossRef | PubMed | Scopus (107)

[67]de Ledinghen, V., Wong, V.W., Vergniol, J., Wong, G.L., Foucher, J., Chu, S.H. et al. Diagnosis of liver fibrosis and cirrhosis using liver stiffness measurement: comparison between M and XL probe of FibroScan(R). J Hepatol. 2012; 56: 833839
Abstract | Full Text | Full Text PDF | PubMed | Scopus (45)

[68]Wong, V.W., Vergniol, J., Wong, G.L., Foucher, J., Chan, A.W., Chermak, F. et al. Liver stiffness measurement using XL probe in patients with nonalcoholic fatty liver disease. Am J Gastroenterol. 2012; 107: 18621871
CrossRef | PubMed | Scopus (25)

[69]Coco, B., Oliveri, F., Maina, A.M., Ciccorossi, P., Sacco, R., Colombatto, P. et al. Transient elastography: a new surrogate marker of liver fibrosis influenced by major changes of transaminases. J Viral Hepat. 2007; 14: 360369
CrossRef | PubMed | Scopus (334)

[70]Sagir, A., Erhardt, A., Schmitt, M., and Haussinger, D. Transient elastography is unreliable for detection of cirrhosis in patients with acute liver damage. Hepatology. 2007; 47: 592595
CrossRef | Scopus (244)

[71]Arena, U., Vizzutti, F., Corti, G., Ambu, S., Stasi, C., Bresci, S. et al. Acute viral hepatitis increases liver stiffness values measured by transient elastography. Hepatology. 2008; 47: 380384
CrossRef | PubMed | Scopus (306)

[72]Millonig, G., Reimann, F.M., Friedrich, S., Fonouni, H., Mehrabi, A., Buchler, M.W. et al. Extrahepatic cholestasis increases liver stiffness (FibroScan) irrespective of fibrosis. Hepatology. 2008; 48: 17181723
CrossRef | PubMed | Scopus (199)

[73]Millonig, G., Friedrich, S., Adolf, S., Fonouni, H., Golriz, M., Mehrabi, A. et al. Liver stiffness is directly influenced by central venous pressure. J Hepatol. 2010; 52: 206210
Abstract | Full Text | Full Text PDF | PubMed | Scopus (130)

[74]Bardou-Jacquet, E., Legros, L., Soro, D., Latournerie, M., Guillygomarch, A., Le Lan, C. et al. Effect of alcohol consumption on liver stiffness measured by transient elastography. World J Gastroenterol. 2013; 19: 516522
CrossRef | PubMed | Scopus (4)

[75]Mueller, S., Millonig, G., Sarovska, L., Friedrich, S., Reimann, F.M., Pritsch, M. et al. Increased liver stiffness in alcoholic liver disease: differentiating fibrosis from steatohepatitis. World J Gastroenterol. 2010; 16: 966972
CrossRef | PubMed | Scopus (38)

[76]Trabut, J.B., Thepot, V., Nalpas, B., Lavielle, B., Cosconea, S., Corouge, M. et al. Rapid decline of liver stiffness following alcohol withdrawal in heavy drinkers. Alcohol Clin Exp Res. 2012; 36: 14071411
CrossRef | PubMed | Scopus (9)

[77]Mederacke, I., Wursthorn, K., Kirschner, J., Rifai, K., Manns, M.P., Wedemeyer, H. et al. Food intake increases liver stiffness in patients with chronic or resolved hepatitis C virus infection. Liver Int. 2009; 29: 15001506
CrossRef | PubMed | Scopus (66)

[78]Arena, U., Lupsor Platon, M., Stasi, C., Moscarella, S., Assarat, A., Bedogni, G. et al. Liver stiffness is influenced by a standardized meal in patients with chronic hepatitis C virus at different stages of fibrotic evolution. Hepatology. 2013; 58: 6572
CrossRef | PubMed | Scopus (32)

[79]Berzigotti, A., De Gottardi, A., Vukotic, R., Siramolpiwat, S., Abraldes, J.G., Garcia-Pagan, J.C. et al. Effect of meal ingestion on liver stiffness in patients with cirrhosis and portal hypertension. PLoS One. 2013; 8: e58742
CrossRef | PubMed | Scopus (21)

[80]Lemoine, M., Shimakawa, Y., Njie, R., Njai, H.F., Nayagam, S., Khalil, M. et al. Food intake increases liver stiffness measurements and hampers reliable values in patients with chronic hepatitis B and healthy controls: the PROLIFICA experience in The Gambia. Aliment Pharmacol Ther. 2014; 39: 188196
CrossRef | Scopus (4)

[81]Bonder, A., Tapper, E.B., and Afdhal, N.H. Contemporary assessment of hepatic fibrosis. Clin Liver Dis. 2015; 19: 123134
Abstract | Full Text | Full Text PDF

[82]Gaia, S., Carenzi, S., Barilli, A.L., Bugianesi, E., Smedile, A., Brunello, F. et al. Reliability of transient elastography for the detection of fibrosis in non-alcoholic fatty liver disease and chronic viral hepatitis. J Hepatol. 2011; 54: 6471
Abstract | Full Text | Full Text PDF | PubMed | Scopus (68)

[83]Boursier, J., de Ledinghen, V., Sturm, N., Amrani, L., Bacq, Y., Sandrini, J. et al. Precise evaluation of liver histology by computerized morphometry shows that steatosis influences liver stiffness measured by transient elastography in chronic hepatitis C. J Gastroenterol. 2014; 49: 527537
CrossRef | PubMed | Scopus (5)

[84]Macaluso, F.S., Maida, M., Camma, C., Cabibbo, G., Cabibi, D., Alduino, R. et al. Steatosis affects the performance of liver stiffness measurement for fibrosis assessment in patients with genotype 1 chronic hepatitis C. J Hepatol. 2014; 61: 523529
Abstract | Full Text | Full Text PDF | Scopus (1)

[85]Wong, V.W., Vergniol, J., Wong, G.L., Foucher, J., Chan, H.L., Le Bail, B. et al. Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease. Hepatology. 2010; 51: 454462
CrossRef | PubMed | Scopus (250)

[86]Arena, U., Vizzutti, F., Abraldes, J.G., Corti, G., Stasi, C., Moscarella, S. et al. Reliability of transient elastography for the diagnosis of advanced fibrosis in chronic hepatitis C. Gut. 2008; 57: 12881293
CrossRef | PubMed | Scopus (125)

[87]Berzigotti, A. and Castera, L. Update on ultrasound imaging of liver fibrosis. J Hepatol. 2013; 59: 180182
Abstract | Full Text | Full Text PDF | PubMed | Scopus (10)

[88]Bamber, J., Cosgrove, D., Dietrich, C.F., Fromageau, J., Bojunga, J., Calliada, F. et al. EFSUMB guidelines and recommendations on the clinical use of ultrasound elastography. Part 1: Basic principles and technology. Ultraschall Med. 2013; 34: 169184
CrossRef | PubMed | Scopus (98)

[89]Nightingale, K., Soo, M.S., Nightingale, R., and Trahey, G. Acoustic radiation force impulse imaging: in vivo demonstration of clinical feasibility. Ultrasound Med Biol. 2002; 28: 227235
Abstract | Full Text | Full Text PDF | PubMed | Scopus (527)

[90]Bota, S., Herkner, H., Sporea, I., Salzl, P., Sirli, R., Neghina, A.M. et al. Meta-analysis: ARFI elastography versus transient elastography for the evaluation of liver fibrosis. Liver Int. 2013; 33: 11381147
CrossRef | PubMed | Scopus (26)

[91]Bota, S., Sporea, I., Sirli, R., Popescu, A., Danila, M., and Costachescu, D. Intra- and interoperator reproducibility of acoustic radiation force impulse (ARFI) elastographypreliminary results. Ultrasound Med Biol. 2012; 38: 11031108
Abstract | Full Text | Full Text PDF | PubMed | Scopus (15)

[92]Boursier, J., Isselin, G., Fouchard-Hubert, I., Oberti, F., Dib, N., Lebigot, J. et al. Acoustic radiation force impulse: a new ultrasonographic technology for the widespread noninvasive diagnosis of liver fibrosis. Eur J Gastroenterol Hepatol. 2010; 22: 10741084
CrossRef | PubMed | Scopus (60)

[93]Guzman-Aroca, F., Frutos-Bernal, M.D., Bas, A., Lujan-Mompean, J.A., Reus, M., Berna-Serna Jde, D. et al. Detection of non-alcoholic steatohepatitis in patients with morbid obesity before bariatric surgery: preliminary evaluation with acoustic radiation force impulse imaging. Eur Radiol. 2012; 22: 25252532
CrossRef | PubMed | Scopus (11)

[94]Popescu, A., Bota, S., Sporea, I., Sirli, R., Danila, M., Racean, S. et al. The influence of food intake on liver stiffness values assessed by acoustic radiation force impulse elastography-preliminary results. Ultrasound Med Biol. 2013; 39: 579584
Abstract | Full Text | Full Text PDF | PubMed | Scopus (10)

[95]Bota, S., Sporea, I., Peck-Radosavljevic, M., Sirli, R., Tanaka, H., Iijima, H. et al. The influence of aminotransferase levels on liver stiffness assessed by Acoustic Radiation Force Impulse Elastography: a retrospective multicentre study. Dig Liver Dis. 2013; 45: 762768
Abstract | Full Text | Full Text PDF | PubMed | Scopus (14)

[96]Muller, M., Gennisson, J.L., Deffieux, T., Tanter, M., and Fink, M. Quantitative viscoelasticity mapping of human liver using supersonic shear imaging: preliminary in vivo feasibility study. Ultrasound Med Biol. 2009; 35: 219229
Abstract | Full Text | Full Text PDF | PubMed | Scopus (143)

[97]Leung, V.Y., Shen, J., Wong, V.W., Abrigo, J., Wong, G.L., Chim, A.M. et al. Quantitative elastography of liver fibrosis and spleen stiffness in chronic hepatitis B carriers: comparison of shear-wave elastography and transient elastography with liver biopsy correlation. Radiology. 2013; 269: 910918
CrossRef | PubMed | Scopus (11)

[98]Poynard, T., Munteanu, M., Luckina, E., Perazzo, H., Ngo, Y., Royer, L. et al. Liver fibrosis evaluation using real-time shear wave elastography: applicability and diagnostic performance using methods without a gold standard. J Hepatol. 2013; 58: 928935
Abstract | Full Text | Full Text PDF | PubMed | Scopus (19)

[99]Elkrief, L., Rautou, P.E., Ronot, M., Lambert, S., Dioguardi Burgio, M., Francoz, C. et al. Prospective comparison of spleen and liver stiffness by using shear-wave and transient elastography for detection of portal hypertension in cirrhosis. Radiology. 2014; : 141210
CrossRef

[100]Cassinotto, C., Lapuyade, B., Mouries, A., Hiriart, J.B., Vergniol, J., Gaye, D. et al. Non-invasive assessment of liver fibrosis with impulse elastography: comparison of Supersonic Shear Imaging with ARFI and FibroScan(R). J Hepatol. 2014; 61: 550557
Abstract | Full Text | Full Text PDF | PubMed | Scopus (4)

[101]Muthupillai, R., Lomas, D.J., Rossman, P.J., Greenleaf, J.F., Manduca, A., and Ehman, R.L. Magnetic resonance elastography by direct visualization of propagating acoustic strain waves. Science. 1995; 269: 18541857
CrossRef | PubMed

[102]Talwalkar, J.A., Yin, M., Fidler, J.L., Sanderson, S.O., Kamath, P.S., and Ehman, R.L. Magnetic resonance imaging of hepatic fibrosis: emerging clinical applications. Hepatology. 2008; 47: 332342
CrossRef | PubMed | Scopus (169)

[103]Chou, R. and Wasson, N. Blood tests to diagnose fibrosis or cirrhosis in patients with chronic hepatitis C virus infection: a systematic review. Ann Intern Med. 2013; 158: 807820
CrossRef | PubMed | Scopus (5)

[104]Poynard, T., Morra, R., Halfon, P., Castera, L., Ratziu, V., Imbert Bismut, F. et al. Meta-analyses of Fibrotest diagnostic value in chronic liver disease. BMC Gastroenterol. 2007; 7: 40
CrossRef | PubMed | Scopus (156)

[105]Lin, Z.H., Xin, Y.N., Dong, Q.J., Wang, Q., Jiang, X.J., Zhan, S.H. et al. Performance of the aspartate aminotransferase-to-platelet ratio index for the staging of hepatitis C-related fibrosis: an updated meta-analysis. Hepatology. 2011; 53: 726736
CrossRef | PubMed | Scopus (106)

[106]Jin, W., Lin, Z., Xin, Y., Jiang, X., Dong, Q., and Xuan, S. Diagnostic accuracy of the aspartate aminotransferase-to-platelet ratio index for the prediction of hepatitis B-related fibrosis: a leading meta-analysis. BMC Gastroenterol. 2012; 12: 14
CrossRef | PubMed | Scopus (23)

[107]Leroy, V., Sturm, N., Faure, P., Trocme, C., Marlu, A., Hilleret, M.N. et al. Prospective evaluation of FibroTest(R), FibroMeter(R), and HepaScore(R) for staging liver fibrosis in chronic hepatitis B: comparison with hepatitis C. J Hepatol. 2014; 61: 2834
Abstract | Full Text | Full Text PDF | PubMed | Scopus (1)

[108]Macias, J., Giron-Gonzalez, J.A., Gonzalez-Serrano, M., Merino, D., Cano, P., Mira, J.A. et al. Prediction of liver fibrosis in human immunodeficiency virus/hepatitis C virus coinfected patients by simple non-invasive indexes. Gut. 2006; 55: 409414
CrossRef | PubMed | Scopus (86)

[109]Loko, M.A., Castera, L., Dabis, F., Le Bail, B., Winnock, M., Coureau, G. et al. Validation and comparison of simple noninvasive indexes for predicting liver fibrosis in HIV-HCV-coinfected patients: ANRS CO3 Aquitaine cohort. Am J Gastroenterol. 2008; 103: 19731980
CrossRef | PubMed | Scopus (35)

[110]Macias, J., Gonzalez, J., Ortega, E., Tural, C., Cabrero, E., Burgos, A. et al. Use of simple noninvasive biomarkers to predict liver fibrosis in HIV/HCV coinfection in routine clinical practice. HIV Med. 2010; 11: 439447
PubMed

[111]Cacoub, P., Carrat, F., Bedossa, P., Lambert, J., Penaranda, G., Perronne, C. et al. Comparison of non-invasive liver fibrosis biomarkers in HIV/HCV co-infected patients: the fibrovic studyANRS HC02. J Hepatol. 2008; 48: 765773
Abstract | Full Text | Full Text PDF | PubMed | Scopus (59)

[112]Cales, P., Halfon, P., Batisse, D., Carrat, F., Perre, P., Penaranda, G. et al. Comparison of liver fibrosis blood tests developed for HCV with new specific tests in HIV/HCV co-infection. J Hepatol. 2010; 53: 238244
Abstract | Full Text | Full Text PDF | Scopus (21)

[113]Cales, P., Laine, F., Boursier, J., Deugnier, Y., Moal, V., Oberti, F. et al. Comparison of blood tests for liver fibrosis specific or not to NAFLD. J Hepatol. 2009; 50: 165173
Abstract | Full Text | Full Text PDF | PubMed | Scopus (86)

[114]McPherson, S., Stewart, S.F., Henderson, E., Burt, A.D., and Day, C.P. Simple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver disease. Gut. 2010; 59: 12651269
CrossRef | PubMed | Scopus (106)

[115]Musso, G., Gambino, R., Cassader, M., and Pagano, G. Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity. Ann Med. 2011; 43: 617649
CrossRef | PubMed | Scopus (194)

[116]Qureshi, K., Clements, R.H., and Abrams, G.A. The utility of the NAFLD fibrosis score in morbidly obese subjects with NAFLD. Obes Surg. 2008; 18: 264270
CrossRef | PubMed | Scopus (16)

[117]Shah, A.G., Lydecker, A., Murray, K., Tetri, B.N., Contos, M.J., and Sanyal, A.J. Comparison of noninvasive markers of fibrosis in patients with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol. 2009; 7: 11041112
Abstract | Full Text | Full Text PDF | PubMed | Scopus (105)

[118]Wong, V.W., Wong, G.L., Chim, A.M., Tse, A.M., Tsang, S.W., Hui, A.Y. et al. Validation of the NAFLD fibrosis score in a Chinese population with low prevalence of advanced fibrosis. Am J Gastroenterol. 2008; 103: 16821688
CrossRef | PubMed | Scopus (41)

[119]Castera, L., Vilgrain, V., and Angulo, P. Noninvasive evaluation of NAFLD. Nat Rev Gastroenterol Hepatol. 2013; 10: 666675
CrossRef | PubMed | Scopus (17)

[120]Parkes, J., Guha, I.N., Roderick, P., and Rosenberg, W. Performance of serum marker panels for liver fibrosis in chronic hepatitis C. J Hepatol. 2006; 44: 462474
Abstract | Full Text | Full Text PDF | PubMed | Scopus (139)

[121]Halfon, P., Bacq, Y., De Muret, A., Penaranda, G., Bourliere, M., Ouzan, D. et al. Comparison of test performance profile for blood tests of liver fibrosis in chronic hepatitis C. J Hepatol. 2007; 46: 395402
Abstract | Full Text | Full Text PDF | PubMed | Scopus (97)

[122]Leroy, V., Hilleret, M.N., Sturm, N., Trocme, C., Renversez, J.C., Faure, P. et al. Prospective comparison of six non-invasive scores for the diagnosis of liver fibrosis in chronic hepatitis C. J Hepatol. 2007; 46: 775782
Abstract | Full Text | Full Text PDF | PubMed | Scopus (153)

[123]Cales, P., de Ledinghen, V., Halfon, P., Bacq, Y., Leroy, V., Boursier, J. et al. Evaluating the accuracy and increasing the reliable diagnosis rate of blood tests for liver fibrosis in chronic hepatitis C. Liver Int. 2008; 28: 13521362
CrossRef | PubMed | Scopus (54)

[124]Degos, F., Perez, P., Roche, B., Mahmoudi, A., Asselineau, J., Voitot, H. et al. Diagnostic accuracy of FibroScan and comparison to liver fibrosis biomarkers in chronic viral hepatitis: a multicenter prospective study (the FIBROSTIC study). J Hepatol. 2010; 53: 10131021
Abstract | Full Text | Full Text PDF | PubMed | Scopus (130)

[125]Zarski, J.P., Sturm, N., Guechot, J., Paris, A., Zafrani, E.S., Asselah, T. et al. Comparison of nine blood tests and transient elastography for liver fibrosis in chronic hepatitis C: The ANRS HCEP-23 study. J Hepatol. 2012; 56: 5562
Abstract | Full Text | Full Text PDF | PubMed | Scopus (48)

[126]Castera, L., Vergniol, J., Foucher, J., Le Bail, B., Chanteloup, E., Haaser, M. et al. Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C. Gastroenterology. 2005; 128: 343350
Abstract | Full Text | Full Text PDF | PubMed | Scopus (1176)

[127]Ziol, M., Handra-Luca, A., Kettaneh, A., Christidis, C., Mal, F., Kazemi, F. et al. Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C. Hepatology. 2005; 41: 4854
CrossRef | PubMed | Scopus (840)

[128]Lupsor, M., Badea, R., Stefanescu, H., Grigorescu, M., Sparchez, Z., Serban, A. et al. Analysis of histopathological changes that influence liver stiffness in chronic hepatitis C. Results from a cohort of 324 patients. J Gastrointestin Liver Dis. 2008; 17: 155163
PubMed

[129]Afdhal, N.H., Bacon, B.R., Patel, K., Lawitz, E.J., Gordon, S.C., Nelson, D.R. et al. Accuracy of fibroscan, compared with histology, in analysis of liver fibrosis in patients with hepatitis B or C: a United States multicenter study. Clin Gastroenterol Hepatol. 2015; 13: e773
Abstract | Full Text | Full Text PDF | Scopus (1)

[130]Oliveri, F., Coco, B., Ciccorossi, P., Colombatto, P., Romagnoli, V., Cherubini, B. et al. Liver stiffness in the hepatitis B virus carrier: a non-invasive marker of liver disease influenced by the pattern of transaminases. World J Gastroenterol. 2008; 14: 61546162
CrossRef | PubMed | Scopus (72)

[131]Marcellin, P., Ziol, M., Bedossa, P., Douvin, C., Poupon, R., de Ledinghen, V. et al. Non-invasive assessment of liver fibrosis by stiffness measurement in patients with chronic hepatitis B. Liver Int. 2009; 29: 242247
CrossRef | PubMed | Scopus (229)

[132]Chan, H.L., Wong, G.L., Choi, P.C., Chan, A.W., Chim, A.M., Yiu, K.K. et al. Alanine aminotransferase-based algorithms of liver stiffness measurement by transient elastography (Fibroscan) for liver fibrosis in chronic hepatitis B. J Viral Hepat. 2009; 16: 3644
CrossRef | PubMed | Scopus (184)

[133]Kim do, Y., Kim, S.U., Ahn, S.H., Park, J.Y., Lee, J.M., Park, Y.N. et al. Usefulness of FibroScan for detection of early compensated liver cirrhosis in chronic hepatitis B. Dig Dis Sci. 2009; 54: 17581763
CrossRef | PubMed | Scopus (55)

[134]Wang, J.H., Changchien, C.S., Hung, C.H., Eng, H.L., Tung, W.C., Kee, K.M. et al. FibroScan and ultrasonography in the prediction of hepatic fibrosis in patients with chronic viral hepatitis. J Gastroenterol. 2009; 44: 439446
CrossRef | PubMed | Scopus (46)

[135]Sporea, I., Sirli, R., Deleanu, A., Tudora, A., Popescu, A., Curescu, M. et al. Liver stiffness measurements in patients with HBV vs. HCV chronic hepatitis: a comparative study. World J Gastroenterol. 2010; 16: 48324837
CrossRef | PubMed | Scopus (25)

[136]Cardoso, A.C., Carvalho-Filho, R.J., Stern, C., Dipumpo, A., Giuily, N., Ripault, M.P. et al. Direct comparison of diagnostic performance of transient elastography in patients with chronic hepatitis B and chronic hepatitis C. Liver Int. 2012; 32: 612621
CrossRef | PubMed | Scopus (40)

[137]Goyal, R., Mallick, S.R., Mahanta, M., Kedia, S., Shalimar, Dhingra, R. et al. Fibroscan can avoid liver biopsy in Indian patients with chronic hepatitis B. J Gastroenterol Hepatol. 2013; 28: 17381745
CrossRef | PubMed | Scopus (3)

[138]de Ledinghen, V., Douvin, C., Kettaneh, A., Ziol, M., Roulot, D., Marcellin, P. et al. Diagnosis of hepatic fibrosis and cirrhosis by transient elastography in HIV/hepatitis C virus-coinfected patients. J Acquir Immune Defic Syndr. 2006; 41: 175179
CrossRef | PubMed | Scopus (260)

[139]Vergara, S., Macias, J., Rivero, A., Gutierrez-Valencia, A., Gonzalez-Serrano, M., Merino, D. et al. The use of transient elastometry for assessing liver fibrosis in patients with HIV and hepatitis C virus coinfection. Clin Infect Dis. 2007; 45: 969974
CrossRef | PubMed | Scopus (104)

[140]Kirk, G.D., Astemborski, J., Mehta, S.H., Spoler, C., Fisher, C., Allen, D. et al. Assessment of liver fibrosis by transient elastography in persons with hepatitis C virus infection or HIV-hepatitis C virus coinfection. Clin Infect Dis. 2009; 48: 963972
CrossRef | PubMed | Scopus (70)

[141]Pineda, J.A., Recio, E., Camacho, A., Macias, J., Almodovar, C., Gonzalez-Serrano, M. et al. Liver stiffness as a predictor of esophageal varices requiring therapy in HIV/hepatitis C virus-coinfected patients with cirrhosis. J Acquir Immune Defic Syndr. 2009; 51: 445449
CrossRef | PubMed | Scopus (13)

[142]Sanchez-Conde, M., Montes-Ramirez, M.L., Miralles, P., Alvarez, J.M., Bellon, J.M., Ramirez, M. et al. Comparison of transient elastography and liver biopsy for the assessment of liver fibrosis in HIV/hepatitis C virus-coinfected patients and correlation with noninvasive serum markers. J Viral Hepat. 2010; 17: 280286
CrossRef | PubMed | Scopus (48)

[143]Castera, L., Winnock, M., Pambrun, E., Paradis, V., Perez, P., Loko, M.A. et al. Comparison of transient elastography (FibroScan), FibroTest, APRI and two algorithms combining these non-invasive tests for liver fibrosis staging in HIV/HCV coinfected patients: ANRS CO13 HEPAVIH and FIBROSTIC collaboration. HIV Med. 2014; 15: 3039
CrossRef | Scopus (5)

[144]Ganne-Carrie, N., Ziol, M., de Ledinghen, V., Douvin, C., Marcellin, P., Castera, L. et al. Accuracy of liver stiffness measurement for the diagnosis of cirrhosis in patients with chronic liver diseases. Hepatology. 2006; 44: 15111517
CrossRef | PubMed | Scopus (303)

[145]Shaheen, A.A., Wan, A.F., and Myers, R.P. FibroTest and FibroScan for the prediction of hepatitis C-related fibrosis: a systematic review of diagnostic test accuracy. Am J Gastroenterol. 2007; 102: 25892600
CrossRef | PubMed | Scopus (200)

[146]Talwalkar, J.A., Kurtz, D.M., Schoenleber, S.J., West, C.P., and Montori, V.M. Ultrasound-based transient elastography for the detection of hepatic Fibrosis: systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2007; 5: 12141220
Abstract | Full Text | Full Text PDF | PubMed | Scopus (237)

[147]Friedrich-Rust, M., Ong, M.F., Martens, S., Sarrazin, C., Bojunga, J., Zeuzem, S. et al. Performance of transient elastography for the staging of liver fibrosis: a meta-analysis. Gastroenterology. 2008; 134: 960974
Abstract | Full Text | Full Text PDF | PubMed | Scopus (582)

[148]Stebbing, J., Farouk, L., Panos, G., Anderson, M., Jiao, L.R., Mandalia, S. et al. A meta-analysis of transient elastography for the detection of hepatic fibrosis. J Clin Gastroenterol. 2010; 44: 214219
CrossRef | PubMed | Scopus (75)

[149]Tsochatzis, E.A., Gurusamy, K.S., Ntaoula, S., Cholongitas, E., Davidson, B.R., and Burroughs, A.K. Elastography for the diagnosis of severity of fibrosis in chronic liver disease: a meta-analysis of diagnostic accuracy. J Hepatol. 2011; 54: 650659
Abstract | Full Text | Full Text PDF | PubMed | Scopus (142)

[150]Chon, Y.E., Choi, E.H., Song, K.J., Park, J.Y., Kim do, Y., Han, K.H. et al. Performance of transient elastography for the staging of liver fibrosis in patients with chronic hepatitis B: a meta-analysis. PLoS One. 2012; 7: e44930
CrossRef | PubMed | Scopus (46)

[151]Nahon, P., Kettaneh, A., Tengher-Barna, I., Ziol, M., de Ledinghen, V., Douvin, C. et al. Assessment of liver fibrosis using transient elastography in patients with alcoholic liver disease. J Hepatol. 2008; 49: 10621068
Abstract | Full Text | Full Text PDF | PubMed | Scopus (90)

[152]Fraquelli, M., Rigamonti, C., Casazza, G., Donato, M.F., Ronchi, G., Conte, D. et al. Etiology-related determinants of liver stiffness values in chronic viral hepatitis B or C. J Hepatol. 2011; 54: 621628
Abstract | Full Text | Full Text PDF | PubMed | Scopus (44)

[153]Maimone, S., Calvaruso, V., Pleguezuelo, M., Squadrito, G., Amaddeo, G., Jacobs, M. et al. An evaluation of transient elastography in the discrimination of HBeAg-negative disease from inactive hepatitis B carriers. J Viral Hepat. 2009; 16: 769774
CrossRef | PubMed | Scopus (24)

[154]Ngo, Y., Benhamou, Y., Thibault, V., Ingiliz, P., Munteanu, M., Lebray, P. et al. An accurate definition of the status of inactive hepatitis B virus carrier by a combination of biomarkers (FibroTest-ActiTest) and viral load. PLoS One. 2008; 3: e2573
CrossRef | PubMed | Scopus (59)

[155]Castera, L., Bernard, P.H., Le Bail, B., Foucher, J., Trimoulet, P., Merrouche, W. et al. Transient elastography and biomarkers for liver fibrosis assessment and follow-up of inactive hepatitis B carriers. Aliment Pharmacol Ther. 2011; 33: 455465
CrossRef | PubMed | Scopus (27)

[156]Yoneda, M., Yoneda, M., Mawatari, H., Fujita, K., Endo, H., Iida, H. et al. Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with nonalcoholic fatty liver disease (NAFLD). Dig Liver Dis. 2008; 40: 371378
Abstract | Full Text | Full Text PDF | PubMed | Scopus (178)

[157]Nobili, V., Vizzutti, F., Arena, U., Abraldes, J.G., Marra, F., Pietrobattista, A. et al. Accuracy and reproducibility of transient elastography for the diagnosis of fibrosis in pediatric nonalcoholic steatohepatitis. Hepatology. 2008; 48: 442448
CrossRef | PubMed | Scopus (133)

[158]Lupsor, M., Badea, R., Stefanescu, H., Grigorescu, M., Serban, A., Radu, C. et al. Performance of unidimensional transient elastography in staging non-alcoholic steatohepatitis. J Gastrointestin Liver Dis. 2010; 19: 5360
PubMed

[159]Petta, S., Di Marco, V., Camma, C., Butera, G., Cabibi, D., and Craxi, A. Reliability of liver stiffness measurement in non-alcoholic fatty liver disease: the effects of body mass index. Aliment Pharmacol Ther. 2011; 33: 13501360
CrossRef | PubMed | Scopus (37)

[160]Brunt, E.M., Janney, C.G., Di Bisceglie, A.M., Neuschwander-Tetri, B.A., and Bacon, B.R. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol. 1999; 94: 24672474
CrossRef | PubMed | Scopus (1799)

[161]Kleiner, D.E., Brunt, E.M., Van Natta, M., Behling, C., Contos, M.J., Cummings, O.W. et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology. 2005; 41: 13131321
CrossRef | PubMed | Scopus (2221)

[162]Foucher, J., Chanteloup, E., Vergniol, J., Castera, L., Le Bail, B., Adhoute, X. et al. Diagnosis of cirrhosis by transient elastography (FibroScan): a prospective study. Gut. 2006; 55: 403408
CrossRef | PubMed | Scopus (603)

[163]Corpechot, C., El Naggar, A., Poujol-Robert, A., Ziol, M., Wendum, D., Chazouilleres, O. et al. Assessment of biliary fibrosis by transient elastography in patients with PBC and PSC. Hepatology. 2006; 43: 11181124
CrossRef | PubMed | Scopus (254)

[164]Corpechot, C., Carrat, F., Poujol-Robert, A., Gaouar, F., Wendum, D., Chazouilleres, O. et al. Noninvasive elastography-based assessment of liver fibrosis progression and prognosis in primary biliary cirrhosis. Hepatology. 2012; 56: 198208
CrossRef | PubMed | Scopus (30)

[165]Nguyen-Khac, E., Chatelain, D., Tramier, B., Decrombecque, C., Robert, B., Joly, J.P. et al. Assessment of asymptomatic liver fibrosis in alcoholic patients using fibroscan: prospective comparison with 7 non-invasive laboratory tests. Aliment Pharmacol Ther. 2008; : 11881198
CrossRef | PubMed | Scopus (70)

[166]Fierbinteanu-Braticevici, C., Andronescu, D., Usvat, R., Cretoiu, D., Baicus, C., and Marinoschi, G. Acoustic radiation force imaging sonoelastography for noninvasive staging of liver fibrosis. World J Gastroenterol. 2009; 15: 55255532
CrossRef | PubMed | Scopus (101)

[167]Friedrich-Rust, M., Wunder, K., Kriener, S., Sotoudeh, F., Richter, S., Bojunga, J. et al. Liver fibrosis in viral hepatitis: noninvasive assessment with acoustic radiation force impulse imaging versus transient elastography. Radiology. 2009; 252: 595604
CrossRef | PubMed | Scopus (285)

[168]Lupsor, M., Badea, R., Stefanescu, H., Sparchez, Z., Branda, H., Serban, A. et al. Performance of a new elastographic method (ARFI technology) compared to unidimensional transient elastography in the noninvasive assessment of chronic hepatitis C. Preliminary results. J Gastrointestin Liver Dis. 2009; 18: 303310
PubMed

[169]Goertz, R.S., Zopf, Y., Jugl, V., Heide, R., Janson, C., Strobel, D. et al. Measurement of liver elasticity with acoustic radiation force impulse (ARFI) technology: an alternative noninvasive method for staging liver fibrosis in viral hepatitis. Ultraschall Med. 2010; 31: 151155
CrossRef | PubMed | Scopus (64)

[170]Takahashi, H., Ono, N., Eguchi, Y., Eguchi, T., Kitajima, Y., Kawaguchi, Y. et al. Evaluation of acoustic radiation force impulse elastography for fibrosis staging of chronic liver disease: a pilot study. Liver Int. 2010; 30: 538545
CrossRef | PubMed | Scopus (123)

[171]Piscaglia, F., Salvatore, V., Di Donato, R., DOnofrio, M., Gualandi, S., Gallotti, A. et al. Accuracy of VirtualTouch Acoustic Radiation Force Impulse (ARFI) imaging for the diagnosis of cirrhosis during liver ultrasonography. Ultraschall Med. 2011; 32: 167175
CrossRef | PubMed | Scopus (53)

[172]Rizzo, L., Calvaruso, V., Cacopardo, B., Alessi, N., Attanasio, M., Petta, S. et al. Comparison of transient elastography and acoustic radiation force impulse for non-invasive staging of liver Fibrosis in patients with chronic hepatitis C. Am J Gastroenterol. 2011; 106: 21122120
CrossRef | PubMed | Scopus (83)

[173]Rifai, K., Cornberg, J., Mederacke, I., Bahr, M.J., Wedemeyer, H., Malinski, P. et al. Clinical feasibility of liver elastography by acoustic radiation force impulse imaging (ARFI). Dig Liver Dis. 2011; 43: 491497
Abstract | Full Text | Full Text PDF | PubMed | Scopus (54)

[174]Sporea, I., Sirli, R.L., Deleanu, A., Popescu, A., Focsa, M., Danila, M. et al. Acoustic radiation force impulse elastography as compared to transient elastography and liver biopsy in patients with chronic hepatopathies. Ultraschall Med. 2011; 32: S46S52
CrossRef | Scopus (74)

[175]Sporea, I., Badea, R., Sirli, R., Lupsor, M., Popescu, A., Danila, M. et al. How efficient is acoustic radiation force impulse elastography for the evaluation of liver stiffness?. Hepat Mon. 2011; 11: 532538
CrossRef

[176]Toshima, T., Shirabe, K., Takeishi, K., Motomura, T., Mano, Y., Uchiyama, H. et al. New method for assessing liver fibrosis based on acoustic radiation force impulse: a special reference to the difference between right and left liver. J Gastroenterol. 2011; 46: 705711
CrossRef | PubMed | Scopus (53)

[177]Colombo, S., Buonocore, M., Del Poggio, A., Jamoletti, C., Elia, S., Mattiello, M. et al. Head-to-head comparison of transient elastography (TE), real-time tissue elastography (RTE), and acoustic radiation force impulse (ARFI) imaging in the diagnosis of liver fibrosis. J Gastroenterol. 2012; 47: 461469
CrossRef | PubMed | Scopus (35)

[178]Sporea, I., Bota, S., Peck-Radosavljevic, M., Sirli, R., Tanaka, H., Iijima, H. et al. Acoustic Radiation Force Impulse elastography for fibrosis evaluation in patients with chronic hepatitis C: an international multicenter study. Eur J Radiol. 2012; 81: 41124118
Abstract | Full Text | Full Text PDF | PubMed | Scopus (36)

[179]Ebinuma, H., Saito, H., Komuta, M., Ojiro, K., Wakabayashi, K., Usui, S. et al. Evaluation of liver fibrosis by transient elastography using acoustic radiation force impulse: comparison with Fibroscan((R)). J Gastroenterol. 2011; 46: 12381248
CrossRef | PubMed | Scopus (16)

[180]Friedrich-Rust, M., Nierhoff, J., Lupsor, M., Sporea, I., Fierbinteanu-Braticevici, C., Strobel, D. et al. Performance of Acoustic Radiation Force Impulse imaging for the staging of liver fibrosis: a pooled meta-analysis. J Viral Hepat. 2012; 19: e212e219
CrossRef | PubMed | Scopus (109)

[181]Nierhoff, J., Chavez Ortiz, A.A., Herrmann, E., Zeuzem, S., and Friedrich-Rust, M. The efficiency of acoustic radiation force impulse imaging for the staging of liver fibrosis: a meta-analysis. Eur Radiol. 2013; 23: 30403053
CrossRef | PubMed | Scopus (20)

[182]Friedrich-Rust, M., Buggisch, P., de Knegt, R.J., Dries, V., Shi, Y., Matschenz, K. et al. Acoustic radiation force impulse imaging for non-invasive assessment of liver fibrosis in chronic hepatitis B. J Viral Hepat. 2013; 20: 240247
CrossRef | PubMed | Scopus (14)

[183]Sporea, I., Sirli, R., Bota, S., Popescu, A., Sendroiu, M., and Jurchis, A. Comparative study concerning the value of acoustic radiation force impulse elastography (ARFI) in comparison with transient elastography (TE) for the assessment of liver fibrosis in patients with chronic hepatitis B and C. Ultrasound Med Biol. 2012; 38: 13101316
Abstract | Full Text | Full Text PDF | PubMed | Scopus (19)

[184]Fierbinteanu Braticevici, C., Sporea, I., Panaitescu, E., and Tribus, L. Value of acoustic radiation force impulse imaging elastography for non-invasive evaluation of patients with nonalcoholic fatty liver disease. Ultrasound Med Biol. 2013; 39: 19421950
Abstract | Full Text | Full Text PDF | PubMed | Scopus (12)

[185]Friedrich-Rust, M., Romen, D., Vermehren, J., Kriener, S., Sadet, D., Herrmann, E. et al. Acoustic radiation force impulse-imaging and transient elastography for non-invasive assessment of liver fibrosis and steatosis in NAFLD. Eur J Radiol. 2012; 81: e325e331
Abstract | Full Text | Full Text PDF | PubMed | Scopus (48)

[186]Palmeri, M.L., Wang, M.H., Rouze, N.C., Abdelmalek, M.F., Guy, C.D., Moser, B. et al. Noninvasive evaluation of hepatic fibrosis using acoustic radiation force-based shear stiffness in patients with nonalcoholic fatty liver disease. J Hepatol. 2011; 55: 666672
Abstract | Full Text | Full Text PDF | PubMed | Scopus (101)

[187]Yoneda, M., Suzuki, K., Kato, S., Fujita, K., Nozaki, Y., Hosono, K. et al. Nonalcoholic fatty liver disease: US-based acoustic radiation force impulse elastography. Radiology. 2010; 256: 640647
CrossRef | PubMed | Scopus (121)

[188]Bavu, E., Gennisson, J.L., Couade, M., Bercoff, J., Mallet, V., Fink, M. et al. Noninvasive in vivo liver fibrosis evaluation using supersonic shear imaging: a clinical study on 113 hepatitis C virus patients. Ultrasound Med Biol. 2011; 37: 13611373
Abstract | Full Text | Full Text PDF | PubMed | Scopus (119)

[189]Ferraioli, G., Tinelli, C., Dal Bello, B., Zicchetti, M., Filice, G., and Filice, C. Accuracy of real-time shear wave elastography for assessing liver fibrosis in chronic hepatitis C: a pilot study. Hepatology. 2012; 56: 21252133
CrossRef | PubMed | Scopus (86)

[190]Piscaglia, F., Marinelli, S., Bota, S., Serra, C., Venerandi, L., Leoni, S. et al. The role of ultrasound elastographic techniques in chronic liver disease: current status and future perspectives. Eur J Radiol. 2014; 83: 450455
Abstract | Full Text | Full Text PDF | Scopus (8)

[191]Crespo, G., Fernandez-Varo, G., Marino, Z., Casals, G., Miquel, R., Martinez, S.M. et al. ARFI, FibroScan, ELF, and their combinations in the assessment of liver fibrosis: a prospective study. J Hepatol. 2012; 57: 281287
Abstract | Full Text | Full Text PDF | PubMed | Scopus (54)

[192]Sporea, I., Sirli, R., Popescu, A., and Danila, M. Acoustic Radiation Force Impulse (ARFI) A new modality for the evaluation of liver fibrosis. Med Ultrasonography. 2010; 12: 2631

[193]Huwart, L., Sempoux, C., Vicaut, E., Salameh, N., Annet, L., Danse, E. et al. Magnetic resonance elastography for the noninvasive staging of liver fibrosis. Gastroenterology. 2008; 135: 3240
Abstract | Full Text | Full Text PDF | PubMed | Scopus (265)

[194]Bohte, A.E., de Niet, A., Jansen, L., Bipat, S., Nederveen, A.J., Verheij, J. et al. Non-invasive evaluation of liver fibrosis: a comparison of ultrasound-based transient elastography and MR elastography in patients with viral hepatitis B and C. Eur Radiol. 2014; 24: 638648
CrossRef | PubMed | Scopus (3)

[195]Ichikawa, S., Motosugi, U., Morisaka, H., Sano, K., Ichikawa, T., Tatsumi, A. et al. Comparison of the diagnostic accuracies of magnetic resonance elastography and transient elastography for hepatic fibrosis. Magn Reson Imaging. 2015; 33: 2630
Abstract | Full Text | Full Text PDF

[196]Castera, L., Le Bail, B., Roudot-Thoraval, F., Bernard, P.H., Foucher, J., Merrouche, W. et al. Early detection in routine clinical practice of cirrhosis and oesophageal varices in chronic hepatitis C: comparison of transient elastography (FibroScan) with standard laboratory tests and non-invasive scores. J Hepatol. 2009; 50: 5968
Abstract | Full Text | Full Text PDF | PubMed | Scopus (171)

[197]Cross, T.J., Calvaruso, V., Maimone, S., Carey, I., Chang, T.P., Pleguezuelo, M. et al. Prospective comparison of Fibroscan, Kings score and liver biopsy for the assessment of cirrhosis in chronic hepatitis C infection. J Viral Hepat. 2010; 17: 546554
CrossRef | Scopus (16)

[198]Wong, G.L., Wong, V.W., Choi, P.C., Chan, A.W., and Chan, H.L. Development of a non-invasive algorithm with transient elastography (Fibroscan) and serum test formula for advanced liver fibrosis in chronic hepatitis B. Aliment Pharmacol Ther. 2010; 31: 10951103
CrossRef | PubMed | Scopus (46)

[199]Boursier, J., de Ledinghen, V., Zarski, J.P., Rousselet, M.C., Sturm, N., Foucher, J. et al. A new combination of blood test and fibroscan for accurate non-invasive diagnosis of liver fibrosis stages in chronic hepatitis C. Am J Gastroenterol. 2011; 106: 12551263
CrossRef | PubMed | Scopus (36)

[200]Boursier, J., de Ledinghen, V., Zarski, J.P., Fouchard-Hubert, I., Gallois, Y., Oberti, F. et al. Comparison of eight diagnostic algorithms for liver fibrosis in hepatitis C: new algorithms are more precise and entirely noninvasive. Hepatology. 2012; 55: 5867
CrossRef | PubMed | Scopus (32)

[201]Kim, B.K., Kim, S.U., Kim, H.S., Park, J.Y., Ahn, S.H., Chon, C.Y. et al. Prospective validation of FibroTest in comparison with liver stiffness for predicting liver fibrosis in Asian subjects with chronic hepatitis B. PLoS One. 2012; 7: e35825
CrossRef | PubMed | Scopus (23)

[202]Wong, G.L., Chan, H.L., Choi, P.C., Chan, A.W., Yu, Z., Lai, J.W. et al. Non-invasive algorithm of enhanced liver fibrosis and liver stiffness measurement with transient elastography for advanced liver fibrosis in chronic hepatitis B. Aliment Pharmacol Ther. 2014; 39: 197208
CrossRef | Scopus (3)

[203]Trembling, P.M., Lampertico, P., Parkes, J., Tanwar, S., Vigano, M., Facchetti, F. et al. Performance of Enhanced Liver Fibrosis test and comparison with transient elastography in the identification of liver fibrosis in patients with chronic hepatitis B infection. J Viral Hepat. 2014; 21: 430438
CrossRef | Scopus (1)

[204]Poynard, T., Ingiliz, P., Elkrief, L., Munteanu, M., Lebray, P., Morra, R. et al. Concordance in a world without a gold standard: a new non-invasive methodology for improving accuracy of fibrosis markers. PLoS One. 2008; 3: e3857
CrossRef | PubMed | Scopus (48)

[205]Boursier, J., Vergniol, J., Sawadogo, A., Dakka, T., Michalak, S., Gallois, Y. et al. The combination of a blood test and Fibroscan improves the non-invasive diagnosis of liver fibrosis. Liver Int. 2009; 29: 15071515
CrossRef | PubMed | Scopus (51)

[206]Sebastiani, G., Vario, A., Guido, M., Noventa, F., Plebani, M., Pistis, R. et al. Stepwise combination algorithms of non-invasive markers to diagnose significant fibrosis in chronic hepatitis C. J Hepatol. 2006; 44: 686693
Abstract | Full Text | Full Text PDF | PubMed | Scopus (182)

[207]Sebastiani, G., Vario, A., Guido, M., and Alberti, A. Sequential algorithms combining non-invasive markers and biopsy for the assessment of liver fibrosis in chronic hepatitis B. World J Gastroenterol. 2007; 13: 525531
CrossRef | PubMed

[208]Sebastiani, G., Halfon, P., Castera, L., Pol, S., Thomas, D.L., Mangia, A. et al. SAFE biopsy: a validated method for large-scale staging of liver fibrosis in chronic hepatitis C. Hepatology. 2009; 49: 18211827
CrossRef | PubMed | Scopus (92)

[209]Bourliere, M., Penaranda, G., Renou, C., Botta-Fridlund, D., Tran, A., Portal, I. et al. Validation and comparison of indexes for fibrosis and cirrhosis prediction in chronic hepatitis C patients: proposal for a pragmatic approach classification without liver biopsies. J Viral Hepat. 2006; 13: 659670
CrossRef | PubMed | Scopus (88)

[210]Sebastiani, G., Halfon, P., Castera, L., Mangia, A., Di Marco, V., Pirisi, M. et al. Comparison of three algorithms of non-invasive markers of fibrosis in chronic hepatitis C. Aliment Pharmacol Ther. 2012; 35: 92104
CrossRef | PubMed | Scopus (17)

[211]Poynard, T., de Ledinghen, V., Zarski, J.P., Stanciu, C., Munteanu, M., Vergniol, J. et al. Relative performances of FibroTest, Fibroscan, and biopsy for the assessment of the stage of liver fibrosis in patients with chronic hepatitis C: a step toward the truth in the absence of a gold standard. J Hepatol. 2012; 56: 541548
Abstract | Full Text | Full Text PDF | PubMed | Scopus (26)

[212]Castera, L., Sebastiani, G., Le Bail, B., de Ledinghen, V., Couzigou, P., and Alberti, A. Prospective comparison of two algorithms combining non-invasive methods for staging liver fibrosis in chronic hepatitis C. J Hepatol. 2010; 52: 191198
Abstract | Full Text | Full Text PDF | PubMed | Scopus (84)

[213]European Association for the Study of the Liver. EASL Clinical Practice Guidelines: management of hepatitis C virus infection. J Hepatol. 2014; 60: 392420
Abstract | Full Text | Full Text PDF | PubMed | Scopus (121)

[214]AASLD/IDSA/IASUSA. Recommendations for testing, managing, and treating hepatitis C; 2015 <http://wwwhcvguidelinesorg> p. Accessed February 19.
http://wwwhcvguidelinesorg

[215]Wong, G.L., Wong, V.W., Choi, P.C., Chan, A.W., Chim, A.M., Yiu, K.K. et al. Increased liver stiffness measurement by transient elastography in severe acute exacerbation of chronic hepatitis B. J Gastroenterol Hepatol. 2009; 24: 10021007
CrossRef | PubMed | Scopus (51)

[216]Wong, G.L., Wong, V.W., Choi, P.C., Chan, A.W., Chim, A.M., Yiu, K.K. et al. Clinical factors associated with liver stiffness in hepatitis B e antigen-positive chronic hepatitis B patients. Clin Gastroenterol Hepatol. 2009; 7: 227233
Abstract | Full Text | Full Text PDF | PubMed | Scopus (31)

[217]Wong, G.L., Wong, V.W., Choi, P.C., Chan, A.W., Chim, A.M., Yiu, K.K. et al. Evaluation of alanine transaminase and hepatitis B virus DNA to predict liver cirrhosis in hepatitis B e antigen-negative chronic hepatitis B using transient elastography. Am J Gastroenterol. 2008; 103: 30713081
CrossRef | PubMed | Scopus (41)

[218]Papatheodoridis, G.V., Manolakopoulos, S., Liaw, Y.F., and Lok, A. Follow-up and indications for liver biopsy in HBeAg-negative chronic hepatitis B virus infection with persistently normal ALT: a systematic review. J Hepatol. 2012; 57: 196202
Abstract | Full Text | Full Text PDF | PubMed | Scopus (42)

[219]Vernon, G., Baranova, A., and Younossi, Z.M. Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults. Aliment Pharmacol Ther. 2011; 34: 274285
CrossRef | PubMed | Scopus (398)

[220]Farrell, G.C., Wong, V.W., and Chitturi, S. NAFLD in Asia As common and important as in the West. Nat Rev Gastroenterol Hepatol. 2013; 10: 307318
CrossRef | PubMed | Scopus (34)

[221]Ekstedt, M., Hagstrom, H., Nasr, P., Fredrikson, M., Stal, P., Kechagias, S. et al. Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up. Hepatology. 2014; DOI: http://dx.doi.org/10.1002/hep.27368
http://dx.doi.org/10.1002/hep.27368 | CrossRef | PubMed

[222]Angulo, P., Bugianesi, E., Bjornsson, E.S., Charatcharoenwitthaya, P., Mills, P.R., Barrera, F. et al. Simple noninvasive systems predict long-term outcomes of patients with nonalcoholic fatty liver disease. Gastroenterology. 2013; 145: e784
Abstract | Full Text | Full Text PDF | Scopus (33)

[223]Kim, D., Kim, W.R., Kim, H.J., and Therneau, T.M. Association between noninvasive fibrosis markers and mortality among adults with nonalcoholic fatty liver disease in the United States. Hepatology. 2013; 57: 13571365
CrossRef | PubMed | Scopus (37)

[224]Wong, V.W., Chu, W.C., Wong, G.L., Chan, R.S., Chim, A.M., Ong, A. et al. Prevalence of non-alcoholic fatty liver disease and advanced fibrosis in Hong Kong Chinese: a population study using proton-magnetic resonance spectroscopy and transient elastography. Gut. 2012; 61: 409415
CrossRef | PubMed | Scopus (82)

[225]Dixon, J.B., Bhathal, P.S., and OBrien, P.E. Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese. Gastroenterology. 2001; 121: 91100
Abstract | Full Text PDF | PubMed

[226]Argo, C.K., Northup, P.G., Al-Osaimi, A.M., and Caldwell, S.H. Systematic review of risk factors for fibrosis progression in non-alcoholic steatohepatitis. J Hepatol. 2009; 51: 371379
Abstract | Full Text | Full Text PDF | PubMed | Scopus (184)

[227]Singh, S., Allen, A.M., Wang, Z., Prokop, L.J., Murad, M.H., and Loomba, R. Fibrosis progression in nonalcoholic fatty liver vs. nonalcoholic steatohepatitis: a systematic review and meta-analysis of paired-biopsy studies. Clin Gastroenterol Hepatol. 2015; 13: 643654 (e9)
Abstract | Full Text | Full Text PDF | Scopus (2)

[228]Wong, V.W., Wong, G.L., Choi, P.C., Chan, A.W., Li, M.K., Chan, H.Y. et al. Disease progression of non-alcoholic fatty liver disease: a prospective study with paired liver biopsies at 3 years. Gut. 2010; 59: 969974
CrossRef | PubMed | Scopus (125)

[229]McPherson, S., Hardy, T., Henderson, E., Burt, A.D., Day, C.P., and Anstee, Q.M. Evidence of NAFLD progression from steatosis to fibrosing-steatohepatitis using paired biopsies: implications for prognosis and clinical management. J Hepatol. 2014; DOI: http://dx.doi.org/10.1016/j.jhep.2014.11.034
http://dx.doi.org/10.1016/j.jhep.2014.11.034 | Abstract | Full Text | Full Text PDF

[230]Pais, R., Charlotte, F., Fedchuk, L., Bedossa, P., Lebray, P., Poynard, T. et al. A systematic review of follow-up biopsies reveals disease progression in patients with non-alcoholic fatty liver. J Hepatol. 2013; 59: 550556
Abstract | Full Text | Full Text PDF | PubMed | Scopus (25)

[231]European Association for the Study of Liver. EASL clinical practical guidelines: management of alcoholic liver disease. J Hepatol. 2012; 57: 399420
Abstract | Full Text | Full Text PDF | PubMed | Scopus (767)

[232]Chrostek, L. and Panasiuk, A. Liver fibrosis markers in alcoholic liver disease. World J Gastroenterol. 2014; 20: 80188023
CrossRef | PubMed | Scopus (3)

[233]Parkes, J., Guha, I.N., Harris, S., Rosenberg, W.M., and Roderick, P.J. Systematic review of the diagnostic performance of serum markers of liver fibrosis in alcoholic liver disease. Comp Hepatol. 2012; 11: 5
CrossRef | PubMed | Scopus (3)

[234]Naveau, S., Gaude, G., Asnacios, A., Agostini, H., Abella, A., Barri-Ova, N. et al. Diagnostic and prognostic values of noninvasive biomarkers of fibrosis in patients with alcoholic liver disease. Hepatology. 2009; 49: 97105
CrossRef | PubMed | Scopus (99)

[235]Parkes, J., Roderick, P., Harris, S., Day, C., Mutimer, D., Collier, J. et al. Enhanced liver fibrosis test can predict clinical outcomes in patients with chronic liver disease. Gut. 2010; 59: 12451251
CrossRef | PubMed | Scopus (88)

[236]Pavlov, C.S., Casazza, G., Nikolova, D., Tsochatzis, E., Burroughs, A.K., Ivashkin, V.T. et al. Transient elastography for diagnosis of stages of hepatic fibrosis and cirrhosis in people with alcoholic liver disease. Cochrane Database Syst Rev. 2015; 1: CD010542

[237]EASL Clinical Practice Guidelines: management of cholestatic liver diseases. J Hepatol. 2009; 51: 237267
Abstract | Full Text | Full Text PDF | PubMed | Scopus (420)

[238]Farkkila, M., Rautiainen, H., Karkkainen, P., Karvonen, A.L., Nurmi, H., and Niemela, O. Serological markers for monitoring disease progression in noncirrhotic primary biliary cirrhosis on ursodeoxycholic acid therapy. Liver Int. 2008; 28: 787797
CrossRef | PubMed | Scopus (9)

[239]Mayo, M.J., Parkes, J., Adams-Huet, B., Combes, B., Mills, A.S., Markin, R.S. et al. Prediction of clinical outcomes in primary biliary cirrhosis by serum enhanced liver fibrosis assay. Hepatology. 2008; 48: 15491557
CrossRef | PubMed | Scopus (74)

[240]Talwalkar, J.A. Current and emerging surrogate markers of hepatic fibrosis in primary biliary cirrhosis. Liver Int. 2008; 28: 761763
CrossRef | Scopus (3)

[241]Voumvouraki, A., Koulentaki, M., Notas, G., Sfakianaki, O., and Kouroumalis, E. Serum surrogate markers of liver fibrosis in primary biliary cirrhosis. Eur J Intern Med. 2011; 22: 7783
Abstract | Full Text | Full Text PDF | Scopus (2)

[242]Floreani, A., Cazzagon, N., Martines, D., Cavalletto, L., Baldo, V., and Chemello, L. Performance and utility of transient elastography and noninvasive markers of liver fibrosis in primary biliary cirrhosis. Dig Liver Dis. 2011; 43: 887892
Abstract | Full Text | Full Text PDF | PubMed

[243]Gomez-Dominguez, E., Mendoza, J., Garcia-Buey, L., Trapero, M., Gisbert, J.P., Jones, E.A. et al. Transient elastography to assess hepatic fibrosis in primary biliary cirrhosis. Aliment Pharmacol Ther. 2008; 27: 441447
CrossRef | PubMed | Scopus (27)

[244]Corpechot, C., Gaouar, F., El Naggar, A., Kemgang, A., Wendum, D., Poupon, R. et al. Baseline values and changes in liver stiffness measured by transient elastography are associated with severity of fibrosis and outcomes of patients with primary sclerosing cholangitis. Gastroenterology. 2014; 146: 970979 (quiz e915e976)
Abstract | Full Text | Full Text PDF | PubMed | Scopus (12)

[245]Shin, N.Y., Kim, M.J., Lee, M.J., Han, S.J., Koh, H., Namgung, R. et al. Transient elastography and sonography for prediction of liver fibrosis in infants with biliary atresia. J Ultrasound Med. 2014; 33: 853864
CrossRef | Scopus (2)

[246]Bjornsson, E., Talwalkar, J., Treeprasertsuk, S., Neuhauser, M., and Lindor, K. Patients with typical laboratory features of autoimmune hepatitis rarely need a liver biopsy for diagnosis. Clin Gastroenterol Hepatol. 2011; 9: 5763
Abstract | Full Text | Full Text PDF | PubMed | Scopus (12)

[247]Dufour, J.F., DeLellis, R., and Kaplan, M.M. Reversibility of hepatic fibrosis in autoimmune hepatitis. Ann Intern Med. 1997; 127: 981985
CrossRef | PubMed

[248]Malekzadeh, R., Mohamadnejad, M., Nasseri-Moghaddam, S., Rakhshani, N., Tavangar, S.M., Sohrabpour, A.A. et al. Reversibility of cirrhosis in autoimmune hepatitis. Am J Med. 2004; 117: 125129
Abstract | Full Text | Full Text PDF | PubMed | Scopus (28)

[249]Romanque, P., Stickel, F., and Dufour, J.F. Disproportionally high results of transient elastography in patients with autoimmune hepatitis. Liver Int. 2008; 28: 11771178
CrossRef | PubMed | Scopus (6)

[250]Afdhal, N.H., Zeuzem, S., Schooley, R.T., Thomas, D.L., Ward, J.W., Litwin, A.H. et al. The new paradigm of hepatitis C therapy: integration of oral therapies into best practices. J Viral Hepat. 2013; 20: 745760
CrossRef

[251]EASL Clinical Practice Guidelines: management of chronic hepatitis B virus infection. J Hepatol. 2012; 57: 167185
Abstract | Full Text | Full Text PDF | PubMed | Scopus (767)

[252]Lok, A.S. and McMahon, B.J. Chronic hepatitis B: update 2009. Hepatology. 2009; 50: 661662
CrossRef | PubMed | Scopus (1204)

[253]Liaw, Y.F., Kao, J.H., Piratvisuth, T., Chan, H.L., Chien, R.N., Liu, C.J. et al. Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2012 update. Hepatol Int. 2012; 6: 531561
CrossRef | Scopus (194)

[254]Poynard, T., Imbert-Bismut, F., Ratziu, V., Chevret, S., Jardel, C., Moussalli, J. et al. Biochemical markers of liver fibrosis in patients infected by hepatitis C virus: longitudinal validation in a randomized trial. J Viral Hepat. 2002; 9: 128133
CrossRef | PubMed | Scopus (185)

[255]Poynard, T., McHutchison, J., Manns, M., Myers, R.P., and Albrecht, J. Biochemical surrogate markers of liver fibrosis and activity in a randomized trial of peginterferon alfa-2b and ribavirin. Hepatology. 2003; 38: 481492
CrossRef | PubMed | Scopus (191)

[256]Fontana, R.J., Bonkovsky, H.L., Naishadham, D., Dienstag, J.L., Sterling, R.K., Lok, A.S. et al. Serum fibrosis marker levels decrease after successful antiviral treatment in chronic hepatitis C patients with advanced fibrosis. Clin Gastroenterol Hepatol. 2009; 7: 219226
Abstract | Full Text | Full Text PDF | PubMed | Scopus (22)

[257]Ogawa, E., Furusyo, N., Toyoda, K., Takeoka, H., Maeda, S., and Hayashi, J. The longitudinal quantitative assessment by transient elastography of chronic hepatitis C patients treated with pegylated interferon alpha-2b and ribavirin. Antiviral Res. 2009; 83: 127134
CrossRef | PubMed | Scopus (57)

[258]Vergniol, J., Foucher, J., Castera, L., Bernard, P.H., Tournan, R., Terrebonne, E. et al. Changes of non-invasive markers and FibroScan values during HCV treatment. J Viral Hepat. 2009; 16: 132140
CrossRef | PubMed | Scopus (59)

[259]Martinez, S.M., Fernandez-Varo, G., Gonzalez, P., Sampson, E., Bruguera, M., Navasa, M. et al. Assessment of liver fibrosis before and after antiviral therapy by different serum marker panels in patients with chronic hepatitis C. Aliment Pharmacol Ther. 2011; 33: 138148
CrossRef | PubMed | Scopus (35)

[260]Hezode, C., Castera, L., Roudot-Thoraval, F., Bouvier-Alias, M., Rosa, I., Roulot, D. et al. Liver stiffness diminishes with antiviral response in chronic hepatitis C. Aliment Pharmacol Ther. 2011; 34: 656663
CrossRef | PubMed | Scopus (25)

[261]Poynard, T., Moussalli, J., Munteanu, M., Thabut, D., Lebray, P., Rudler, M. et al. Slow regression of liver fibrosis presumed by repeated biomarkers after virological cure in patients with chronic hepatitis C. J Hepatol. 2013; 59: 675683
Abstract | Full Text | Full Text PDF | PubMed | Scopus (14)

[262]Stasi, C., Arena, U., Zignego, A.L., Corti, G., Monti, M., Triboli, E. et al. Longitudinal assessment of liver stiffness in patients undergoing antiviral treatment for hepatitis C. Dig Liver Dis. 2013; 45: 840843
Abstract | Full Text | Full Text PDF | PubMed | Scopus (3)

[263]Vergniol, J., Boursier, J., Coutzac, C., Bertrais, S., Foucher, J., Angel, C. et al. Evolution of noninvasive tests of liver fibrosis is associated with prognosis in patients with chronic hepatitis C. Hepatology. 2014; 60: 6576
CrossRef | PubMed | Scopus (8)

[264]Poynard, T., McHutchison, J., Manns, M., Trepo, C., Lindsay, K., Goodman, Z. et al. Impact of pegylated interferon alfa-2b and ribavirin on liver fibrosis in patients with chronic hepatitis C. Gastroenterology. 2002; 122: 13031313
Abstract | Full Text | Full Text PDF | PubMed

[265]Shiratori, Y., Imazeki, F., Moriyama, M., Yano, M., Arakawa, Y., Yokosuka, O. et al. Histologic improvement of fibrosis in patients with hepatitis C who have sustained response to interferon therapy. Ann Intern Med. 2000; 132: 517524
CrossRef | PubMed

[266]DAmbrosio, R., Aghemo, A., Fraquelli, M., Rumi, M.G., Donato, M.F., Paradis, V. et al. The diagnostic accuracy of Fibroscan for cirrhosis is influenced by liver morphometry in HCV patients with a sustained virological response. J Hepatol. 2013; 59: 251256
Abstract | Full Text | Full Text PDF | PubMed | Scopus (8)

[267]Klibansky, D.A., Mehta, S.H., Curry, M., Nasser, I., Challies, T., and Afdhal, N.H. Transient elastography for predicting clinical outcomes in patients with chronic liver disease. J Viral Hepat. 2012; 19: e184e193
CrossRef | PubMed | Scopus (20)

[268]Vergniol, J., Foucher, J., Terrebonne, E., Bernard, P.H., le Bail, B., Merrouche, W. et al. Noninvasive tests for fibrosis and liver stiffness predict 5-year outcomes of patients with chronic hepatitis C. Gastroenterology. 2011; 140: 19701979 (1979, e1971e1973)
Abstract | Full Text | Full Text PDF | PubMed | Scopus (122)

[269]Chang, T.T., Liaw, Y.F., Wu, S.S., Schiff, E., Han, K.H., Lai, C.L. et al. Long-term entecavir therapy results in the reversal of fibrosis/cirrhosis and continued histological improvement in patients with chronic hepatitis B. Hepatology. 2010; 52: 886893
CrossRef | PubMed | Scopus (254)

[270]Hadziyannis, S.J., Tassopoulos, N.C., Heathcote, E.J., Chang, T.T., Kitis, G., Rizzetto, M. et al. Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B for up to 5 years. Gastroenterology. 2006; 131: 17431751
Abstract | Full Text | Full Text PDF | PubMed | Scopus (575)

[271]Marcellin, P., Gane, E., Buti, M., Afdhal, N., Sievert, W., Jacobson, I.M. et al. Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study. Lancet. 2013; 381: 468475
Abstract | Full Text | Full Text PDF | PubMed | Scopus (187)

[272]Poynard, T., Zoulim, F., Ratziu, V., Degos, F., Imbert-Bismut, F., Deny, P. et al. Longitudinal assessment of histology surrogate markers (FibroTest-ActiTest) during lamivudine therapy in patients with chronic hepatitis B infection. Am J Gastroenterol. 2005; 100: 19701980
CrossRef | PubMed | Scopus (103)

[273]Poynard, T., Ngo, Y., Marcellin, P., Hadziyannis, S., Ratziu, V., and Benhamou, Y. Impact of adefovir dipivoxil on liver fibrosis and activity assessed with biochemical markers (FibroTest-ActiTest) in patients infected by hepatitis B virus. J Viral Hepat. 2009; 16: 203213
CrossRef | PubMed | Scopus (33)

[274]Wong, G.L., Wong, V.W., Choi, P.C., Chan, A.W., Chim, A.M., Yiu, K.K. et al. On-treatment monitoring of liver fibrosis with transient elastography in chronic hepatitis B patients. Antivir Ther. 2011; 16: 165172
CrossRef | PubMed | Scopus (28)

[275]Fung, J., Lai, C.L., Wong, D.K., Seto, W.K., Hung, I., and Yuen, M.F. Significant changes in liver stiffness measurements in patients with chronic hepatitis B: 3-year follow-up study. J Viral Hepat. 2011; 18: e200e205
CrossRef | PubMed | Scopus (18)

[276]Ogawa, E., Furusyo, N., Murata, M., Ohnishi, H., Toyoda, K., Taniai, H. et al. Longitudinal assessment of liver stiffness by transient elastography for chronic hepatitis B patients treated with nucleoside analog. Hepatol Res. 2011; 41: 11781188
CrossRef | PubMed | Scopus (15)

[277]Enomoto, M., Mori, M., Ogawa, T., Fujii, H., Kobayashi, S., Iwai, S. et al. Usefulness of transient elastography for assessment of liver fibrosis in chronic hepatitis B: regression of liver stiffness during entecavir therapy. Hepatol Res. 2010; 40: 853861
CrossRef | PubMed | Scopus (28)

[278]Osakabe, K., Ichino, N., Nishikawa, T., Sugiyama, H., Kato, M., Kitahara, S. et al. Reduction of liver stiffness by antiviral therapy in chronic hepatitis B. J Gastroenterol. 2011; 46: 13241334
CrossRef | PubMed | Scopus (19)

[279]Lim, S.G., Cho, S.W., Lee, Y.C., Jeon, S.J., Lee, M.H., Cho, Y.J. et al. Changes in liver stiffness measurement during antiviral therapy in patients with chronic hepatitis B. Hepatogastroenterology. 2011; 58: 539545
PubMed

[280]Kuo, Y.H., Lu, S.N., Chen, C.H., Chang, K.C., Hung, C.H., Tai, W.C. et al. The changes of liver stiffness and its associated factors for chronic hepatitis B patients with entecavir therapy. PLoS One. 2014; 9: e93160
CrossRef | PubMed

[281]Poynard, T., Vergniol, J., Ngo, Y., Foucher, J., Thibault, V., Munteanu, M. et al. Staging chronic hepatitis B into seven categories, defining inactive carriers and assessing treatment impact using a fibrosis biomarker (FibroTest(R)) and elastography (FibroScan(R)). J Hepatol. 2014; 61: 9941003
Abstract | Full Text | Full Text PDF

[282]de Ledinghen, V., Vergniol, J., Barthe, C., Foucher, J., Chermak, F., Le Bail, B. et al. Non-invasive tests for fibrosis and liver stiffness predict 5-year survival of patients chronically infected with hepatitis B virus. Aliment Pharmacol Ther. 2013; 37: 979988
CrossRef | PubMed | Scopus (17)

[283]Lee, H.W., Yoo, E.J., Kim, B.K., Kim, S.U., Park, J.Y., Kim do, Y. et al. Prediction of development of liver-related events by transient elastography in hepatitis B patients with complete virological response on antiviral therapy. Am J Gastroenterol. 2014; 109: 12411249
CrossRef | PubMed | Scopus (2)

[284]Kim, M.N., Kim, S.U., Kim, B.K., Park, J.Y., Kim, D.Y., Ahn, S.H. et al. Increased risk of hepatocellular carcinoma in chronic hepatitis B patients with transient elastography-defined subclinical cirrhosis. Hepatology. 2015; DOI: http://dx.doi.org/10.1002/hep.27735
http://dx.doi.org/10.1002/hep.27735 | CrossRef

[285]Carrion, J.A., Navasa, M., Bosch, J., Bruguera, M., Gilabert, R., and Forns, X. Transient elastography for diagnosis of advanced fibrosis and portal hypertension in patients with hepatitis C recurrence after liver transplantation. Liver Transpl. 2006; 12: 17911798
CrossRef | PubMed | Scopus (237)

[286]Vizzutti, F., Arena, U., Romanelli, R.G., Rega, L., Foschi, M., Colagrande, S. et al. Liver stiffness measurement predicts severe portal hypertension in patients with HCV-related cirrhosis. Hepatology. 2007; 45: 12901297
CrossRef | PubMed | Scopus (291)

[287]Bureau, C., Metivier, S., Peron, J.M., Selves, J., Robic, M.A., Gourraud, P.A. et al. Transient elastography accurately predicts presence of significant portal hypertension in patients with chronic liver disease. Aliment Pharmacol Ther. 2008; 27: 12611268
CrossRef | PubMed | Scopus (122)

[288]Lemoine, M., Katsahian, S., Ziol, M., Nahon, P., Ganne-Carrie, N., Kazemi, F. et al. Liver stiffness measurement as a predictive tool of clinically significant portal hypertension in patients with compensated hepatitis C virus or alcohol-related cirrhosis. Aliment Pharmacol Ther. 2008; 28: 11021110
CrossRef | PubMed | Scopus (57)

[289]Shi, K.Q., Fan, Y.C., Pan, Z.Z., Lin, X.F., Liu, W.Y., Chen, Y.P. et al. Transient elastography: a meta-analysis of diagnostic accuracy in evaluation of portal hypertension in chronic liver disease. Liver Int. 2013; 33: 6271
CrossRef | PubMed | Scopus (26)

[290]Llop, E., Berzigotti, A., Reig, M., Erice, E., Reverter, E., Seijo, S. et al. Assessment of portal hypertension by transient elastography in patients with compensated cirrhosis and potentially resectable liver tumors. J Hepatol. 2012; 56: 103108
Abstract | Full Text | Full Text PDF | PubMed | Scopus (25)

[291]Reiberger, T., Ferlitsch, A., Payer, B.A., Pinter, M., Homoncik, M., and Peck-Radosavljevic, M. Non-selective beta-blockers improve the correlation of liver stiffness and portal pressure in advanced cirrhosis. J Gastroenterol. 2012; 47: 561568
CrossRef | PubMed | Scopus (23)

[292]Carrion, J.A., Torres, F., Crespo, G., Miquel, R., Garcia-Valdecasas, J.C., Navasa, M. et al. Liver stiffness identifies two different patterns of fibrosis progression in patients with hepatitis C virus recurrence after liver transplantation. Hepatology. 2010; 51: 2334
CrossRef | PubMed | Scopus (71)

[293]Crespo, G., Lens, S., Gambato, M., Carrion, J.A., Marino, Z., Londono, M.C. et al. Liver stiffness 1 year after transplantation predicts clinical outcomes in patients with recurrent hepatitis C. Am J Transplant. 2014; 14: 375383
CrossRef | PubMed | Scopus (2)

[294]Kazemi, F., Kettaneh, A., NKontchou, G., Pinto, E., Ganne-Carrie, N., Trinchet, J.C. et al. Liver stiffness measurement selects patients with cirrhosis at risk of bearing large oesophageal varices. J Hepatol. 2006; 45: 230235
Abstract | Full Text | Full Text PDF | PubMed | Scopus (217)

[295]Nguyen-Khac, E., Saint-Leger, P., Tramier, B., Coevoet, H., Capron, D., and Dupas, J.L. Noninvasive diagnosis of large esophageal varices by fibroscan: strong influence of the cirrhosis etiology. Alcohol Clin Exp Res. 2010; 34: 11461153
PubMed

[296]Pritchett, S., Cardenas, A., Manning, D., Curry, M., and Afdhal, N.H. The optimal cut-off for predicting large oesophageal varices using transient elastography is disease specific. J Viral Hepat. 2011; 18: e75e80
CrossRef | PubMed | Scopus (26)

[297]Castera, L., Pinzani, M., and Bosch, J. Non invasive evaluation of portal hypertension using transient elastography. J Hepatol. 2012; 56: 696703
Abstract | Full Text | Full Text PDF | PubMed | Scopus (54)

[298]Stefanescu, H., Grigorescu, M., Lupsor, M., Procopet, B., Maniu, A., and Badea, R. Spleen stiffness measurement using Fibroscan for the noninvasive assessment of esophageal varices in liver cirrhosis patients. J Gastroenterol Hepatol. 2011; 26: 164170
CrossRef | PubMed | Scopus (49)

[299]Takuma, Y., Nouso, K., Morimoto, Y., Tomokuni, J., Sahara, A., Toshikuni, N. et al. Measurement of spleen stiffness by acoustic radiation force impulse imaging identifies cirrhotic patients with esophageal varices. Gastroenterology. 2012; 144: e102

[300]Colecchia, A., Montrone, L., Scaioli, E., Bacchi-Reggiani, M.L., Colli, A., Casazza, G. et al. Measurement of spleen stiffness to evaluate portal hypertension and the presence of esophageal varices in patients with HCV-related cirrhosis. Gastroenterology. 2012; 143: 646654
Abstract | Full Text | Full Text PDF | PubMed | Scopus (76)

[301]Sharma, P., Kirnake, V., Tyagi, P., Bansal, N., Singla, V., Kumar, A. et al. Spleen stiffness in patients with cirrhosis in predicting esophageal varices. Am J Gastroenterol. 2013; 108: 11011107
CrossRef | PubMed | Scopus (22)

[302]Calvaruso, V., Bronte, F., Conte, E., Simone, F., Craxi, A., and Di Marco, V. Modified spleen stiffness measurement by transient elastography is associated with presence of large oesophageal varices in patients with compensated hepatitis C virus cirrhosis. J Viral Hepat. 2013; 20: 867874
CrossRef | PubMed | Scopus (5)

[303]Giannini, E., Botta, F., Borro, P., Risso, D., Romagnoli, P., Fasoli, A. et al. Platelet count/spleen diameter ratio: proposal and validation of a non-invasive parameter to predict the presence of oesophageal varices in patients with liver cirrhosis. Gut. 2003; 52: 12001205
CrossRef | PubMed | Scopus (177)

[304]Giannini, E.G., Zaman, A., Kreil, A., Floreani, A., Dulbecco, P., Testa, E. et al. Platelet count/spleen diameter ratio for the noninvasive diagnosis of esophageal varices: results of a multicenter, prospective, validation study. Am J Gastroenterol. 2006; 101: 25112519
CrossRef | PubMed | Scopus (100)

[305]Kim, B.K., Han, K.H., Park, J.Y., Ahn, S.H., Kim, J.K., Paik, Y.H. et al. A liver stiffness measurement-based, noninvasive prediction model for high-risk esophageal varices in B-viral liver cirrhosis. Am J Gastroenterol. 2010; 105: 13821390
CrossRef | PubMed | Scopus (54)

[306]Park, S.H., Park, T.E., Kim, Y.M., Kim, S.J., Baik, G.H., Kim, J.B. et al. Non-invasive model predicting clinically-significant portal hypertension in patients with advanced fibrosis. J Gastroenterol Hepatol. 2009; 24: 12891293
CrossRef | PubMed | Scopus (7)

[307]Thabut, D., Imbert-Bismut, F., Cazals-Hatem, D., Messous, D., Muntenau, M., Valla, D.C. et al. Relationship between the Fibrotest and portal hypertension in patients with liver disease. Aliment Pharmacol Ther. 2007; 26: 359368
CrossRef | PubMed | Scopus (36)

[308]Sebastiani, G., Tempesta, D., Fattovich, G., Castera, L., Halfon, P., Bourliere, M. et al. Prediction of oesophageal varices in hepatic cirrhosis by simple serum non-invasive markers: results of a multicenter, large-scale study. J Hepatol. 2010; 53: 630638
Abstract | Full Text | Full Text PDF | PubMed | Scopus (28)

[309]Thabut, D., Trabut, J.B., Massard, J., Rudler, M., Muntenau, M., Messous, D. et al. Non-invasive diagnosis of large oesophageal varices with FibroTest in patients with cirrhosis: a preliminary retrospective study. Liver Int. 2006; 26: 271278
CrossRef | PubMed | Scopus (64)

[310]Feier, D., Lupsor Platon, M., Stefanescu, H., and Badea, R. Transient elastography for the detection of hepatocellular carcinoma in viral C liver cirrhosis. Is there something else than increased liver stiffness?. J Gastrointestin Liver Dis. 2013; 22: 283289

[311]Kuo, Y.H., Lu, S.N., Hung, C.H., Kee, K.M., Chen, C.H., Hu, T.H. et al. Liver stiffness measurement in the risk assessment of hepatocellular carcinoma for patients with chronic hepatitis. Hepatol Int. 2010; 4: 700706
CrossRef | Scopus (11)

[312]Masuzaki, R., Tateishi, R., Yoshida, H., Yoshida, H., Sato, S., Kato, N. et al. Risk assessment of hepatocellular carcinoma in chronic hepatitis C patients by transient elastography. J Clin Gastroenterol. 2008; 42: 839843
CrossRef | PubMed | Scopus (34)

[313]Nahon, P., Kettaneh, A., Lemoine, M., Seror, O., Barget, N., Trinchet, J.C. et al. Liver stiffness measurement in patients with cirrhosis and hepatocellular carcinoma: a case-control study. Eur J Gastroenterol Hepatol. 2009; 21: 214219
CrossRef | Scopus (9)

[314]Akima, T., Tamano, M., and Hiraishi, H. Liver stiffness measured by transient elastography is a predictor of hepatocellular carcinoma development in viral hepatitis. Hepatol Res. 2011; 41: 965970
CrossRef | PubMed | Scopus (10)

[315]Chon, Y.E., Jung, E.S., Park, J.Y., Kim do, Y., Ahn, S.H., Han, K.H. et al. The accuracy of noninvasive methods in predicting the development of hepatocellular carcinoma and hepatic decompensation in patients with chronic hepatitis B. J Clin Gastroenterol. 2012; 46: 518525
CrossRef | PubMed | Scopus (17)

[316]Jung, K.S., Kim, S.U., Ahn, S.H., Park, Y.N., Kim do, Y., Park, J.Y. et al. Risk assessment of hepatitis B virus-related hepatocellular carcinoma development using liver stiffness measurement (FibroScan). Hepatology. 2011; 53: 885894
CrossRef | PubMed | Scopus (97)

[317]Masuzaki, R., Tateishi, R., Yoshida, H., Goto, E., Sato, T., Ohki, T. et al. Prospective risk assessment for hepatocellular carcinoma development in patients with chronic hepatitis C by transient elastography. Hepatology. 2009; 49: 19541961
CrossRef | PubMed | Scopus (132)

[318]Narita, Y., Genda, T., Tsuzura, H., Sato, S., Kanemitsu, Y., Ishikawa, S. et al. Prediction of liver stiffness hepatocellular carcinoma in chronic hepatitis C patients on interferon-based anti-viral therapy. J Gastroenterol Hepatol. 2014; 29: 137143
CrossRef

[319]Wang, H.M., Hung, C.H., Lu, S.N., Chen, C.H., Lee, C.M., Hu, T.H. et al. Liver stiffness measurement as an alternative to fibrotic stage in risk assessment of hepatocellular carcinoma incidence for chronic hepatitis C patients. Liver Int. 2013; 33: 756761
CrossRef | Scopus (8)

[320]Kim do, Y., Song, K.J., Kim, S.U., Yoo, E.J., Park, J.Y., Ahn, S.H. et al. Transient elastography-based risk estimation of hepatitis B virus-related occurrence of hepatocellular carcinoma: development and validation of a predictive model. Onco Targets Ther. 2013; 6: 14631469

[321]Kim, S.U., Lee, J.H., Kim do, Y., Ahn, S.H., Jung, K.S., Choi, E.H. et al. Prediction of liver-related events using fibroscan in chronic hepatitis B patients showing advanced liver fibrosis. PLoS One. 2012; 7: e36676
CrossRef | PubMed | Scopus (29)

[322]Robic, M.A., Procopet, B., Metivier, S., Peron, J.M., Selves, J., Vinel, J.P. et al. Liver stiffness accurately predicts portal hypertension related complications in patients with chronic liver disease: A prospective study. J Hepatol. 2011; 55: 10171024
Abstract | Full Text | Full Text PDF | PubMed | Scopus (79)

[323]Poynard, T., Vergniol, J., Ngo, Y., Foucher, J., Munteanu, M., Merrouche, W. et al. Staging chronic hepatitis C in seven categories using fibrosis biomarker (FibroTest) and transient elastography (FibroScan(R)). J Hepatol. 2014; 60: 706714
Abstract | Full Text | Full Text PDF | PubMed | Scopus (6)

[324]Wong, G.L., Chan, H.L., Wong, C.K., Leung, C., Chan, C.Y., Ho, P.P. et al. Liver stiffness-based optimization of hepatocellular carcinoma risk score in patients with chronic hepatitis B. J Hepatol. 2014; 60: 339345
Abstract | Full Text | Full Text PDF | PubMed | Scopus (8)

[325]Wong, V.W., Chan, S.L., Mo, F., Chan, T.C., Loong, H.H., Wong, G.L. et al. Clinical scoring system to predict hepatocellular carcinoma in chronic hepatitis B carriers. J Clin Oncol. 2010; 28: 16601665
CrossRef | PubMed | Scopus (76)

[326]Merchante, N., Rivero-Juarez, A., Tellez, F., Merino, D., Jose Rios-Villegas, M., Marquez-Solero, M. et al. Liver stiffness predicts clinical outcome in human immunodeficiency virus/hepatitis C virus-coinfected patients with compensated liver cirrhosis. Hepatology. 2012; 56: 228238
CrossRef | PubMed | Scopus (21)

[327]Macias, J., Camacho, A., Von Wichmann, M.A., Lopez-Cortes, L.F., Ortega, E., Tural, C. et al. Liver stiffness measurement versus liver biopsy to predict survival and decompensations of cirrhosis among HIV/hepatitis C virus-coinfected patients. Aids. 2013; 27: 25412549
CrossRef | Scopus (1)

[328]Pang, J.X., Zimmer, S., Niu, S., Crotty, P., Tracey, J., Pradhan, F. et al. Liver stiffness by transient elastography predicts liver-related complications and mortality in patients with chronic liver disease. PLoS One. 2014; 9: e95776
CrossRef | Scopus (5)

[329]Colecchia, A., Colli, A., Casazza, G., Mandolesi, D., Schiumerini, R., Reggiani, L.B. et al. Spleen stiffness measurement can predict clinical complications in compensated HCV-related cirrhosis: a prospective study. J Hepatol. 2014; 60: 11581164
Abstract | Full Text | Full Text PDF | Scopus (4)

[330]Ngo, Y., Munteanu, M., Messous, D., Charlotte, F., Imbert-Bismut, F., Thabut, D. et al. A prospective analysis of the prognostic value of biomarkers (FibroTest) in patients with chronic hepatitis C. Clin Chem. 2006; 52: 18871896
CrossRef | PubMed | Scopus (155)

[331]Nunes, D., Fleming, C., Offner, G., Craven, D., Fix, O., Heeren, T. et al. Noninvasive markers of liver fibrosis are highly predictive of liver-related death in a cohort of HCV-infected individuals with and without HIV infection. Am J Gastroenterol. 2010; 105: 13461353
CrossRef | PubMed | Scopus (57)

[332]Ghany, M.G., Lok, A.S., Everhart, J.E., Everson, G.T., Lee, W.M., Curto, T.M. et al. Predicting clinical and histologic outcomes based on standard laboratory tests in advanced chronic hepatitis C. Gastroenterology. 2010; 138: 136146
Abstract | Full Text | Full Text PDF | PubMed | Scopus (45)

[333]Fontana, R.J., Dienstag, J.L., Bonkovsky, H.L., Sterling, R.K., Naishadham, D., Goodman, Z.D. et al. Serum fibrosis markers are associated with liver disease progression in non-responder patients with chronic hepatitis C. Gut. 2010; 59: 14011409
CrossRef | PubMed | Scopus (44)